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Abstract
How does the Affordable Care Act (2010) address intimate partner violence and its health
impacts on survivors? Is there evidence that this legislation positively impacts access to health
services for survivors? I seek to compare provisions under the first major piece of federal
legislation addressing gender-based violence, the Violence Against Women Act of 1994, to the
major policy reforms of the Affordable Care Act. I examine this question through legislative
histories of the relevant portions of the Affordable Care Act and the Violence Against Women
Act addressing intimate partner violence. In order to examine the Affordable Care Act’s impact
on survivors’ and their health, I will analyze health service mandates, the medical community
response, and federal intervention program funding between these two federal acts. In particular,
I focus my study on community health centers as sites most responsive to health coverage
expansions, providing accessible care to patients most underserved and at the greatest risk for
violence. Through this study, I illustrate how the Affordable Care Act’s service and funding
mandates improve upon prior legislation, and impact access and quality of care for survivors.
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Introduction
On average, over 20 people per minute are victims of rape, physical violence, or stalking
by an intimate partner in the U.S., yet only 34% of people who are injured by intimate partners
receive health care for their injuries (NCADV 2017). There is growing consensus among
women’s rights activists, public health advocates, and policymakers that intimate partner
violence (IPV) is a national crisis of public health, human rights, and sexual and reproductive
autonomy. IPV is “one of the most common forms of violence against women, and includes
physical, sexual, and emotional abuse and controlling behaviors by an intimate partner” (WHO
2012, 1). IPV is a distinct form of interpersonal violence, characterized by intentional
exploitation of intimacy and power in intimate relationships (Mitchell and James 2009). The
most prevalent form of IPV consists of male intimate partners or ex-partners exerting violence or
coercion against women (Bonomi et al 2007; Mitchell 2009). Intimate partner violence is
commonly equated with domestic violence and sexual assault or harassment, and is the most
common cause of injury to women in the U.S. (Heron 2009). Mental and physical effects of IPV
therefore present a widespread health issue impacting all levels of the health care system,
particularly health clinics servicing the most under resourced and at-risk communities.
Yet, despite recognition that IPV is a pervasive issue in the U.S. causing immediate and
long-term harm across all regions and demographic groups, a notable lack of policy attention is
given to IPV at all levels of government. Through this paper, I am interested in understanding
how federal healthcare policy legislation and funding serve to define and address IPV. I
specifically examine the most sweeping federal health care reform of recent decades, the Patient
Protection and Affordable Care Act (2010) (ACA), in comparison to the first major piece of
federal legislation addressing gender-based violence, the Violence Against Women Act of 1994
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(VAWA) (Mitchell and James 2009; Runge 2013). While the original 1994 legislation focused
almost singularly on a criminal justice response to IPV, its subsequent reauthorizations began to
expand protections within a health care framework as well. The ACA signifies the most
significant policy reforms, both to the healthcare system in general, and for IPV interventions in
the over two decades since VAWA’s initial passage (Lizotte 2016; Sonfield and Park 2013).
Through this paper, I aim to fill a gap in existing scholarship by bringing a seminal view through
the lens of IPV to evaluate how the ACA changes VAWA, and represents an evolution in federal
health policy, in terms of its extension of both mandated services and funding for survivors’1
services. In particular, I use federally funded community health centers (CHCs) as a case study
of sites where the ACA has the potential to be most impactful, reaching the most underserved
and at-risk communities. This contributes a new perspective to the literature on health policy and
IPV, as little research has yet studied the specific relationship between the ACA and survivors,
nor revealed the longer-term impact of the law. I hope that this research will enhance
understanding of evolving federal legislation, with the aim of improving future policy-making
that prioritizes survivor health.
Furthermore, my driving research question is: how does the ACA address IPV and its
health impacts on survivors, particularly within CHCs, and how does this mark a departure from
VAWA provisions? The methodology I use to answer this critical question is effectively
conducting a legislative history and policy analysis of the ACA through an IPV lens, focusing on
12 key sections of the statute. I trace the formulation and evolution of IPV federal health policy
from VAWA 1994 through the ACA. My research design is threefold in that I integrate
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
1	
  I use the term “survivor” to refer to persons who are either currently experiencing IPV, or have been exposed to
violence or threats of violence in the past. Discourse and terminology varies by the framework for understanding
IPV, with the criminal justice system tending to use the term “victim,” while sexual assault and domestic violence
advocates prefer the term of “survivor.” As this paper seeks to move beyond the criminal justice framework for IPV
interventions, focusing on more empowering and health-focused programs, I use the term “survivor” or “patient.”	
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legislative histories, analyses of government reports and secondary data, and funding allocations
for comprehensive health services in CHCs.
I illustrate how the Affordable Care Act’s service and funding mandates improve upon
prior legislation, and impact access and quality of care for survivors. Utilizing legislative and
policy analysis, this study concluded that the ACA represents a positive step forward in
advancing federal IPV policy beyond VAWA provisions, which were largely limited to a legal
and criminal justice response to IPV. My study will prove useful in directing future policy not
only in its evaluation of the ACA and how it reforms VAWA provisions, but also in highlighting
the degree to which IPV continues to lack sufficient public and policymaker attention even under
the ACA, particularly considering its widespread prevalence and magnitude. In this way, my
elucidation of areas for improvement under the ACA through service expansions and longer-term
program funding guarantees can also inform the development of policy. I conclude by
emphasizing the necessity of more accessible, affordable, long-term, comprehensive services and
prevention for survivors that go beyond criminal justice and emergency medicine, and funding
for these mandates.
This paper is divided into six main sections focusing on the ACA, its policy provisions
and funding for IPV, and the potential health impacts for survivors. I begin with a Background
section explaining IPV, its occurrence within the U.S., and individual and societal risk factors
most associated with victimization. Establishing the magnitude of IPV as a public health
problem, and the factors that precipitate this violence, is essential to this paper’s study of how the
ACA addresses survivor health outcomes through both programs and funding. In the second
section, I then discuss the relevant literature by drawing on public health scholars, policymakers,
and women’s rights advocates in order to contextualize VAWA and the ACA’s health policy
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provisions. The third section presents my Research Design and Methodology, which includes
conducting both legislative histories and policy and funding analyses, primarily through
qualitative analysis of bill text and government and secondary reports. In the Data and Results
section, I conduct legislative histories of the relevant portions of the VAWA and the ACA,
coupled with policy and funding analysis of services for survivors at CHCs under the ACA.
Finally, the Discussion section compares changes for health care provisions for survivors
between VAWA and the ACA. I conclude my analysis with a summary of my evaluation of the
ACA’s comprehensiveness and effectiveness in addressing IPV survivor health, as well as
present policy recommendations for improving upon existing legislation.
Background
A complete understanding of both IPV, and the ways in which pre-ACA legislation
addressed IPV, are essential to contextualize the central questions of this paper and frame my
analysis of health policy under the ACA. IPV constitutes a U.S. public health crisis, with
profound and detrimental implications for overall mental and physical health, as well as sexual
and reproductive health and autonomy. While I discuss IPV’s health impacts in greater detail in
the Literature Review, it is important to first emphasize the widespread, pervasive nature of
violence, as IPV occurs across all settings and among all socioeconomic, religious, and cultural
population groups (WHO 2012, 1). IPV encompasses acts of stalking psychological aggression,
physical violence or sexual violence, as well as the threats of these acts (Breiding MJ et al 2015).
Drawing on the prevailing definitions from the Centers for Disease Control and Prevention
(CDC) and the World Health Organization (WHO), an “intimate partner” is a “person to whom
someone is currently or has been intimately connected, such as a spouse or domestic partner, a
boyfriend or girlfriend, or a dating or ongoing sexual partner” (Breiding MJ et al 2015). This
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type of violence can occur among cohabitating or non-cohabitating heterosexual or same-sex
couples. In the context of this definition, other forms of family violence, such as childhood
sexual abuse and elder abuse, do not fall under the scope of IPV. While each form of family
violence is characterized by exploitation of power imbalances within close relationships, IPV is
unparalleled in its impact on reproductive health, and is distinct in the romantic or sexual ties
defining the intimate relationship. Therefore, forms of family violence beyond this precise
explanation of IPV are not addressed within this paper’s specific analysis of IPV health policy.
IPV constitutes a form of reproductive control, in which an individual’s partner uses
intimidation and threats of violence to impose the partner’s own intentions upon the individual’s
sexual autonomy, impeding reproductive choice and health. While the problem of IPV affects
people from all types of demographic backgrounds, on both a national and global level this crisis
disproportionately impacts women and adolescent girls (Hasstedt and Rowan 2016). Women
who experience intersecting inequalities, such as transgender women, LGBTQ women, and
women of color, statistically face an even greater risk for IPV and reproductive control, resulting
in the dominant framing of IPV as “violence against women” within the public health field.
Violence against women occurs at extremely high rates across the U.S., with estimates
reporting that between one in four and one in three women will experience physical or sexual
abuse by an intimate partner during her lifetime (Cramer 2004; Mitchell and James 2009).
According to leading research and policy organizations surveying sexual and reproductive rights,
nearly half of U.S. women experience psychological aggression from an intimate partner, one in
four are subjected to “severe” physical violence, and at least one in 10 are raped by an intimate
partner over the course of their lifetime. Plus, one-third of murders of women in the U.S. result
from violence by a current or former male intimate partner (Hasstedt and Rowan 2016). As a
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result of these extremely high incidences of abuse, IPV is the most common cause of injury to
women in the U.S. (Heron 2009, 105).
Risk of abuse and victimization are closely tied with specific individual, familial, and
societal-level factors that heighten the likelihood of exposure to violence. On an individual
patient level, medical providers diagnose IPV as an “actual or threatened physical, sexual, or
psychological violence perpetrated by current or former partners” (Pico-Alfonso et al 2006, 600).
IPV is associated with several individual risks for victimization, with women who are under 35
years of age, individuals lacking medical insurance, and individuals with partners abusing drugs
and alcohol being particularly subject to harm (Heron 2009; Warshaw, Brashler 2009). Within
families of origin, IPV is tied to a cycle of violence narrative. Women who are physically or
sexually abused as children, or who witness their mothers being abused, face greater risk for
victimization in both adolescence and adulthood, as these factors are strongly predictive of future
relationship abuse (Warshaw, Brashler, and Gil 2009, 149).
Alcohol and substance abuse are empirically related to elevated rates of both IPV
perpetration and victimization, with alcohol dependence correlated to acts of marital aggression
(Cunradi 2009, 174). In this sense, specific patterns of heavy drinking and of drug use constitute
both causes and consequences of IPV within the context of individuals and couples. It is likely
that couples experiencing drinking-related social consequences or alcohol-dependence symptoms
have higher levels of marital discord, fights, and verbal aggression, placing the couple at greater
risk for IPV. Conversely, recent alcohol-related problems may be indicators of couples whose
drinking behaviors and interpersonal relationship have deteriorated from a healthy relationship
behavioral status. Cunradi (2009, 177) explicates the involvement of alcohol as having both
disinhibiting effect on healthy conflict resolution, and acting as a “discriminative cue” justifying
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or excusing violent behavior. Substance abuse, violent behavior, and the overarching public
health issue of IPV become inextricably linked in that they historically lack sufficient federallevel allocation of targeted support services, and are important predictors of IPV diagnosis.
Looking beyond such individual and family-level risk factors, populations at the greatest
risk for IPV victimization principally stem from communities most lacking in resources and
social support services, and most traditionally underserved by health policy and providers. It is
therefore critical that this paper examines access to care for survivors in health care settings,
particularly looking at changes between VAWA and the ACA, to note policy advancements
attempting to alleviate this significant public health strain on vulnerable communities. Risk of
IPV is exacerbated by gender and socioeconomic factors, including poverty, homelessness,
unsafe living conditions, and physical or financial dependence on caregivers (Warshaw,
Brashler, Gil 2009, 151). Inadequate income, lack of available affordable housing, and the
vulnerability of women fleeing domestic violence compound problems of IPV by placing women
in temporary or unstable living conditions. (Heron 2009, 108). Scholars examining societal
factors for victimization routinely point to low socioeconomic status, low insurance status,
partner unemployment, low levels of partner education, and poor access to social support
services as correlates with experiences of IPV (Cunradi 2009; Heron 2009; Warshaw and
Brashler 2009).
Other scholars go beyond history of trauma and individual socioeconomic factors to
highlight U.S. societal and cultural factors influencing IPV prevalence. Immigration status is an
example of a significant, yet little-studied societal factor for victimization; limited language
skills, isolation from contact with family and community, diminished access to jobs, and
uncertain legal status exacerbate the immigrant population’s victimization rate (Heron 2009,
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109). In addition, the feminist perspective informs Cramer (2004) and Runge’s (2013)
discussions of the evolution of health policy addressing IPV, elucidating the role of
institutionalized patriarchal violence and control. Warshaw and Brashler’s argument relating to
mental health treatment for survivors makes the additional point that “although experiencing or
witnessing abuse in childhood may place women at greater risk for being abused as adults, the
major risk factor for partner abuse is living in a society that tolerates gender-based violence”
(2009, 338). This combination of individual factors, trauma history, and societal and
socioeconomic factors are inextricably linked to overall societal health and prosperity. Because
IPV has such a far-reaching impact on U.S. individuals, families, and overall societal health and
well-being, understanding and addressing IPV within a health care framework is extremely
important for examining the ACA and crafting comprehensive federal health policy (Heron
2009, 109).

Literature Review
In order to contextualize both the Violence Against Women Act and the Affordable Care
Act’s provisions, I begin my analysis by exploring three broader areas of scholarship regarding
IPV: (A) medical provider studies detailing IPV and its broad-ranging health impacts; (B)
legislative and policy analyses of federal legislation addressing violence against; and (C) public
health and advocate best practices for addressing IPV in health provider.
A. Intimate Partner Violence Impact on Survivor Health Outcomes and the Healthcare
Industry
Intimate partner violence inflicts significant costs on U.S. societal health and economic
productivity. For example, recent estimates of public health costs associated with IPV exceed
eight billion dollars annually, including more than one billion dollars associated with life lost
(Hasstedt and Rowan 2016; NCADV 2017). IPV places burdens on all levels of the healthcare
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system, which is generally ill equipped to deal with the complexity of IPV victimization, or with
the added strain of patient volume and resources used. The health care industry is particularly
impacted by IPV incidences in that the health arena is an entry point for many survivors of
violence to begin to access care. Clinicians and counselors largely serve as this entry point in
identifying and treating patients seeking care for IPV-related symptoms, and by providing an
opportunity for survivors to report.
IPV survivors experience broad-ranging, and often long-lasting symptoms that can
undermine physical, reproductive, psychological, and behavioral health outcomes and overall
well-being. Studies conducted by the medical community have largely focused on exploring the
relationship between IPV and general health, the types and severity of symptoms, and
assessment of symptom-syndromes (Nicolaidis and Leibshultz 2009). IPV is strongly associated
with overall inferior general health, as well as wide-ranging physical symptoms that persist
beyond immediate or emergent injury caused by physical assault. Women with histories of past
physical or sexual IPV victimization exhibit an increased number of chronic and severe physical
symptoms, ranging from hearing loss and sexually transmitted infections (STIs) to syndromes
such as fibromyalgia, irritable bowel syndrome (IBS), and chronic pelvic pain (Nicolaidis and
Leibshultz 2009, 135). These conditions persist even years after the cessation of IPV abuse.
Intimate partner sexual abuse presents a related yet distinct problem of IPV, with strong
associations between intimate partner sexual abuse and STIs, pelvic inflammatory disease,
bladder infections, urinary tract infections, and damage to fertility and the overall reproductive
system (Sachs and Gomberg 2009).
IPV compromises healthy reproductive relationships and reproductive health, and poses a
heightened risk for pregnant survivors. Beyond domestic violence and sexual violence, IPV
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includes forms of reproductive control such as contraceptive sabotage, pressuring a woman to
become pregnant against her will, and coercive abortion. IPV is a contributory factor in high-risk
sexual behavior, STIs, Human-immunodeficiency virus (HIV), multiple or coerced pregnancies,
and pregnancy loss (Bonomi et al 2007; Gee 2012). It is estimated that between 3.9 and 8.3
percent of pregnant women experience IPV, making IPV as prevalent of a health problem as
gestational diabetes and preeclampsia (Goodman 2009, 254). The medical community’s
consensus identifying IPV as a significant problem for pregnant women represents an important
step in informing both my analysis of the ACA, and my explication of best practices and future
policy recommendations. Pregnancy facilitates a significant increase in the number of
interactions between women, their partners, and healthcare providers, resulting in increased
opportunities for intervention for women who are experiencing IPV (Goodman 2009, 253).
Pregnancy may be the primary opportunity for a health female patient to interact with healthcare
providers specializing in reproductive health services (Goodman 2009, 258), creating an opening
to discuss a patient’s home situation, safety issues, and options to address symptoms.
Physical symptoms are inextricably linked to survivor mental health, with an extremely
high co-occurrence of chronic pain and Post-traumatic Stress Disorder (PTSD) (Nicolaidis and
Leibshultz 2009, 137; Pico-Alfonso et al 2006). IPV patients consistently present with higher
pain intensity, diminished coping skills, and greater physical and psychological disability than
patients not experiencing PTSD or IPV trauma. Poor coping skills commonly manifest in
additional health problems, eating disorders, and substance abuse, as IPV survivors attempt to
escape the effects of abuse and regain a sense of control (Cunradi 2009; Warshaw, Brashler, Gil
2009). Exposure to current or past abuse is a significant factor in both development and
exacerbation of psychiatric disorders, plus increases the risk of future victimization and
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influences the course of recovery from mental illness. Survivors of IPV routinely present with
heightened symptoms of depression, anxiety, suicidality, and overwhelming feelings of loss of
control over their own lives (Warshaw, Brashler, Gil 2009).
The adverse physical and mental health impacts of IPV even extend to accessibility and
affordability of health care. In comparison to women not experiencing this violence, IPV
survivors exhibit increased utilization of healthcare services as a result of their heightened risk
for physical and mental injury (Nicolaidis and Leibshultz 2009). Survivors typically have higher
out of pocket healthcare costs as well, particularly because survivors historically represent the
populations most at risk to be uninsured, or to lack access to affordable care (Anglin 2009, 88).
Cost and affordability represent critical barriers to survivors seeking comprehensive services
from healthcare providers. IPV also imposes a significant economic impact in that survivors lose
a total of eight million days of paid work each year, resulting in millions of these survivors
losing their jobs due to reasons stemming from the abuse (NCADV 2017). Coupled with high
frequency of medical visits and health care costs, this employment loss further impedes
survivors’ ability to pay for all necessary services, and generates a vicious cycle of
inaccessibility of care.
Studies of women presenting IPV to healthcare providers additionally report patterns of
partners interfering with their access to health care, resulting in limited access to services,
noncompliance with scheduled appointments and medications, and even retaliation for seeking
care (Anglin 2009, 87). One study of women reporting IPV in a health care setting (Anglin 2009)
displayed that over 17 percent reported their partners interfering with their health care, compared
to two percent rate of partner interference of women not experiencing IPV (Anglin 2009;
Hamberger 2009). Particularly for financially dependent survivors, such barriers exacerbate
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difficulties in accessing increasingly expensive treatments and supports. This point exemplifies
why it is imperative to address IPV through federal health policy, with the goal of ensuring that
services reach survivors; this supports my overall research question tracing policy comparisons
between VAWA and the ACA.
Examining such risk factors and health consequences of IPV underscores the necessity of
focusing greater attention on survivor supports through healthcare providers and federal health
policy. Understandings of both broad trends in IPV exposure and its short and long-term related
health issues can be highly informative in policymaking to expand care overall, and address
specific needs of survivors. In pursuit of this goal, policymakers must understand areas for
improvement in existing legislation regarding violence against women, identify what services are
needed to help survivors, what barriers to care currently exist, and how major policy reforms can
target these coverage barriers.
B. Federal Policy Regarding Violence Against Women: History and Limitations
Regardless of the framework used to define IPV, scholars increasingly recognize that this
issue has been historically under-addressed, and even ignored, in U.S. federal legislation.
Legislation that does target this violence largely fails to recognize IPV as a public health issue.
Contemporaneous recognition of these limitations is reflected both in heightened media attention
paid to violence against women, and in a prominent increase in scholarly literature analyzing
IPV best practices within the period from VAWA to the present. Prior to the 1970s, scholars,
government officials, and wider society predominantly explained IPV through victim-blaming
theories. Cramer (2004), Howe and Alpert (2009), Mitchell and Vanya (2009), and Sachs and
Gomberg (2009) provide background to their studies of evolving health policy, and its traditional
avoidance of the IPV crisis, by explaining that violent incidents were justified as private matters
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within the home, with women faulted for their husband’s violence. Interference by law
enforcement officials or government policy was highly discouraged. By the end of the 1970s,
however, activist feminist groups and domestic violence advocates opened battered women’s
shelters to address this “hidden problem” of domestic and sexual violence. Advocates coupled
these early service provisions with a call for judicial systems to treat IPV as a formalized crime,
rather than ignoring the issue as minor family feuds of little concern to policymakers (Cramer
2004, 164).
Despite substantial increases in services, funding, and government policy supporting
survivors since the 1970s, IPV remains an often overlooked, underfunded problem still
predominantly addressed within a narrow criminal justice framework. Rather than emphasizing
services for survivors, the primary goal of the criminal justice response is to obtain a conviction
of offenders (Cramer 2004; Howe and Alpert 2009; Modi et al 2014). Criminal justice policy
presents few remedies beyond legal restraints, deterrence, and treatment for offenders, with no
emphasis on prevention or treatment (Mitchell and James 2009). This singularly criminal
justice-centered response exhibits several negative unintended consequences. Up to threequarters of IPV survivors do not report the assault to the police--largely out of fear of law
enforcement treatment or arrest and inability to pay for potential legal fees--resulting in a
considerable number of women who are not being served by the criminal justice system or
receiving any connections to care (Cramer 2004, 170).
Health advocates criticize the criminal justice response as ineffective and disempowering,
advocating instead for a clinical, feminist, or public health intervention paradigm. In particular,
the batterer intervention programs promoted by law enforcement are viewed as overly
confrontational and lacking cultural sensitivity (Cramer 2004, Modi et al 2014). The criminal
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justice response is one of reactionary intervention, occurring only after an assault or threat of
violence. This perspective is ineffective in screening for, or preventing violence, particularly
taking into account that many men who engage in abusive behaviors are not previously
documented within the criminal justice system prior to perpetration. Public health advocates
increasingly promote a new paradigm for addressing IPV, moving beyond this limited, offenderfocused criminal justice response to one in which survivors’ mental and physical well-being is
the central focus. Survivors interact with the health care system on a much more regular and
personal level than with the criminal justice system through both routine and abuse-related care.
Providers in all settings should be prepared and resource-equipped to identify, support, and refer
(Anglin 2009; O’Campo et al 2011; Oehme and Stern 2014; McCaw and Kotz 2009).
The shortcomings of maintaining the criminal justice model, rather than a public health
and prevention focus, persist under VAWA legislation, reiterating the need for reexamination
and reform in federal IPV policy. VAWA 1994 marked the first major piece of federal legislation
specifically addressing gender-based violence, and elevating domestic violence and sexual
assault to federal policy priorities (Laney 2010; Manchikanti et al 2017; Modi et al 204; Runge
2013). While Congress did conduct a series of hearings in the early 1980s to understand the
scope of violence against women, culminating in the passage of the Family Violence Prevention
and Services Act (FVPSA) in 1984, this law is limited in scope and in its operational definitions
of violence (Fernandes-Alcantara 2017). FVPSA includes federal grants for shelter services,
coordination of state and local advocates, public awareness campaigns, and a National Domestic
Violence Hotline. However, FVPSA funds cannot reimburse for the provision of health services,
and therefore fail to adequately address IPV as a public health crisis (Hasstedt and Rowan 2016).
With the passage of VAWA 1994 (P.L. 103-122) under Title IV of the Violent Crime and Law
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Enforcement Act of 1994, Congress amended the FVPSA to greatly expand federal support
explicitly for domestic violence prevention and response. While the FVSPA emphasized
prevention and services for victims of more generalized violence, VAWA’s primary goals were
to clearly criminalize rape, domestic assault, stalking, and other forms of violence against
women, and to increase penalties for these acts as serious offenses (Boba and Lilley 2009;
Fernandes-Alcantara 2017). Boba and Lilley note that through VAWA’s passage, Congress sent
the message that crimes of gender-based violence do not merely constitute private disputes, but
are punishable criminal behaviors deserving of national attention.
Mitchell and James argue that the VAWA Prevent (Title IV) and VAWA Health (Title V)
sections of VAWA’s 2005 reauthorization were “among the first legislation to address a
healthcare response or public health approach to violence at the federal level” (2009, 10). The
majority of federal funding under VAWA 1994, and other legislation directed at IPV, is
distributed to states for law enforcement and some community-based services. VAWA Health
and VAWA Prevent, however, take steps towards a health system response to break
intergenerational cycles of violence and provide resources aiding health professionals to better
identify survivors (Mitchell and James 2009). Despite these initial attempts to move beyond the
law enforcement model to a more comprehensive approach, VAWA largely failed to address
funding and service mandates to ensure the implementation of such health services.
Correspondingly, attempts to update and improve upon policy for IPV must be evaluated based
on the extent to which they provide institutionalized support to promote access to health care not
just in theory, but also in practice.
In moving beyond VAWA legislation, public health scholars and the Family Violence
Prevention fund released a 2009 report suggesting six core components for consideration in
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developing a comprehensive health policy. According to these scholars, core components
include: (1) education for health care professionals, (2) protocols and policies that support health
care assessment, (3) prevention of insurance discrimination against domestic violence survivors,
(4) funding grants to address IPV in the health setting, (5) collaborative prevention and early
intervention wellness programs, such as through CHCs, and (6) further research efforts (Macy et
al 2010; Mitchell and James 2009). Grants and funding allocations, in particular, are necessary to
build the capacity of health professional to identify, address, and prevent IPV, as well as to
promote local, community-specific programs. As this scholarship was predominantly drafted
prior to the passage of the ACA, these debates are profoundly informative in creating a standard
for comparison in my evaluation of the ACA’s effectiveness for survivors.
C. Addressing Intimate Partner Violence in Healthcare Provider Settings: Best Practices
and the Affordable Care Act
As a significant reformation of federal health policy, the ACA represents an opportunity
to improve upon VAWA’s criminal justice-centered programs, shifting to a greater health,
prevention, and social support focus. The ACA must be considered not only in comparison to
the previously established policy under VAWA, but also in terms of the degree to which its
provisions effectively implement best practices for addressing IPV. In examining legislation like
the ACA, public health scholars and IPV survivor advocates address the complex question of
how best to intervene in a healthcare provider setting in a manner that encourages disclosure and
protects survivors from retraumatization. O’Campo et al analyzed reports by advocates exploring
the inner mechanisms of health care interventions, aiming to make explicit the underlying
theories of what makes IPV intervention programs effective. Defining “comprehensive”
programs as those that offer numerous screening components at multiple levels and benefitting
from healthcare provider institutional support, O’Campo et al identified common components of
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effective interventions: thorough initial and ongoing training for healthcare providers,
standardized and systematic screening protocols, and immediate access to referral or onsite
support services.
Similarly, O’Campo et al, Macy et al, and others encourage this public health policy
model as a way not only to support survivors, but also to diminish the treatment and disclosure
barriers identified by the medical community response to IPV. In contrast to the criminal justice
response, a public health response principally aims to improve survivor health outcomes. This is
indicated by both increased mandates and funding allocation for services that are accessible,
affordable, and comprehensive. Public health advocates’ studies reveal, “the availability of
support services that enable the victim to address their short- and long-term health, social, and
safety needs emerged as another important component of comprehensive programs” (O’Campo
et al 2011, 862). Screening and intervention protocols remain ineffectual in promoting survivors’
positive health outcomes if they are not coupled with access to mental health services, safe and
confidential spaces, both primary and reproductive health care, and referrals to community social
service agencies (O’Campo et al 2011).
Despite broad scholarly consensus of the negative health impacts of IPV, large segments
of the population are not provided with comprehensive screenings, counseling, or other services
to address IPV through a health care setting. As a result, healthcare provider settings represent
both an underutilized opportunity, and a site for major improvement, in the potential to identify,
refer, and promote intervention to address the needs of IPV survivors. Prevention and screening
efforts are undermined by the persistent stigmatization of IPV, engrained traditions of victimblaming, the coercive nature of violence, and a deficiency of effective training, assessment tools,
and community resources for healthcare providers (Anglin 2009; Iyengar 2009; Larkin and Parks
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2009; Macy et al 2010; Mitchell and Vanya 2009; O’Campo et al 2011). On a personal level,
IPV survivors may face denial, embarrassment, and fear of retaliation or backlash from their
peers and intimate partners if they disclose abuse to healthcare providers (Anglin 2009, 90). IPV
patients report fears of heightened violence or revictimization, and are consequently deterred
from disclosure both by poorly trained healthcare providers, and by the potential for law
enforcement involvement. Stemming from the systems of control that characterize IPV,
survivors may have difficulty in trusting a healthcare provider, or may be particularly sensitive to
control issues in the patient-provider relationship (Nicolaidis and Leibshultz 2009, 139). As a
result, primary concerns in improving federal health policy prioritize creating an atmosphere of
acceptance and validation, safe spaces to disclose and seek care, and destigmatization of abuse
and mental health problems (Larkin and Parks 2009; Warshaw, Brashler, and Gil 2009).
Scholarship exploring barriers to disclosure in health settings emphasize these
professional, personal, and institutional barriers for the healthcare provider in positively
encouraging IPV disclosure and intervention. Healthcare providers at all levels, including
emergency care workers and primary care providers, not only exhibit misconceptions about the
nature of IPV, but demonstrate personal biases, and subscribe to the persisting belief that IPV is
a private, rather than public health or healthcare issue (Macy et al 2010). These personal barriers
effectively inhibit medical professionals from implementing screening and prevention for their
patients. Personal biases and fears of offending patients are coupled with substantial professional
barriers, including appointment time constraints, ineffective training about interventions, and
lack of appropriate services to which to refer patients (Anglin 2009, 90).
Recognizing the limitations of existing services, advocates center their recommendations
for programs essential to survivors based on both past experiences working with survivors, as
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well as on the recommendations of several comprehensive studies by the Institute of Medicine
(IOM), the United States Preventive Services Task Force (USPSTF), and other national
healthcare organizations. In 2011, the IOM released a report highlighting the prevalence of IPV
in the U.S., and recommending “screening and counseling for all women and adolescent girls for
interpersonal and domestic violence in a culturally sensitive and supportive manner” (Miller et al
2015, 92). Within the broader public health community, screening is defined as “the use of a test,
examination, or other procedure rapidly applied in an asymptomatic population to identify
individuals with early disease” (Miller et al 2015, 93). However, IPV remains such a stigmatized
and “silent” problem that many survivors are not truly asymptomatic when screened; patients
exhibit a pattern of suppressing or hiding symptoms in order to avoid this stigmatization.
Effective screening within the IPV context therefore requires healthcare providers to be armed
with the necessary tools for sensitive, informed, and empathetic inquiry.
Screening for IPV involves careful navigation of multiple levels of patient interface and
intervention. This involves primary prevention for patients with no history of exposure,
secondary prevention addressing patients with past exposure, and tertiary prevention efforts for
patients with current or emergent experiences of violence (Howe and Alpert 2009; Miller et al
2015). Settings that provide 24-hour on-site advocacy, community collaboration with external
domestic violence advocates, adoption of protocols for routine inquiry, and ongoing
multidisciplinary training have indicated the most improvement in care provisions. This
improvement is exhibited through measures such as increased rates of routine inquiry, case
finding, referrals, provider self-efficacy, and even rates of patient satisfaction with provider care
(Larkin and Parks 2009; 314). To best address survivors at multiple levels of violence exposure,
and to mitigate the personal and institutional barriers to screening and counseling, scholars
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emphasize the need for greater training, education, and resources for healthcare providers. Best
practices promoting survivor safety, confidentiality, and connection with comprehensive
counseling services must be coupled with primary care clinics hiring of specialized staff
members dedicated to IPV interventions.
The ACA is distinct from previous legislation addressing IPV, and from prior health
policy legislation, in general, in that it centralizes convergence of wellness and prevention, as
opposed to reactionary or disease treatment-focused interventions (Jacobson and Dahlen 2016;
Mayer et al 2015; Oberlander 2016; Oehme and Stern 2014). Despite several implementation
challenges, including difficulties in establishing new institutions, educating the public, and
persuading reluctant policymakers, (Beland et al 2016; Corman and Levin 2016; Oberlander
2015), the ACA’s targeting of persistently uninsured and underserved communities makes it a
central piece of legislation to effectively study the ability of federal health policy to improve
well-being of individuals who are survivors or at risk for violence (Atsas and Kunz 2014; Beland
et al 2016; Sonfield and Pollack 2013; Stolp and Gox 2013; Williams 2016). Specifically, the
ACA’s special provisions bolstering care for at-risk communities allow for expansion of
reproductive care services and service utilization (Mears and Visher 2005; Stapleton and Skinner
2015; Stulberg 2013). As noted by Stulberg, the ACA “has great potential to improve the
reproductive health of the U.S. population. Expanded coverage of young adults and the
reproductive health services they seek will not only benefit current patients but will allow us to
learn and improve care for the benefit of future users” (2013, 453). Gee (2012) and Sonfield et al
(2013) expand upon the conclusions of scholars who examine ACA implementation more
broadly, further detailing potential gains and serious challenges to the ACA’s treatment of
reproductive health, and, consequently, IPV survivor health.
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Drawing together these three categories of literature related to IPV health effects, the

evolution of federal policy addressing violence against women, and best practices for medical
providers’ response to IPV reveals a noteworthy gap in comprehensive services addressing longterm health needs of survivors, including at CHCs. While the VAWA and its three
reauthorizations provide vital resources to survivors, since this legislation was formulated within
the criminal justice model, it consequently lacks a central focus on wide-ranging health policy.
As the ACA marks the most far-reaching reform of health policy and funding since VAWA, I
study this legislation with a critical eye to determine the extent to which the ACA effectively
satisfies the core components and best practices of comprehensive policy called for by the public
health community. In particular, this analysis focuses on the provisions of the ACA related to
providing care for survivors in an affordable, community-centered, coordinated manner. I pay
heightened attention to the ACA’s mandate for services, funding, and enforcement within the
context of federally qualified CHCs as sites of greatest potential impact.
Research Design and Methodology
I conduct qualitative, inductive research into the relationship between health policy under
the ACA and federal provisions for IPV survivors, focusing on survivors’ access to care. My
central research question is: How does the ACA address IPV and its health impacts on survivors?
Sub-questions supporting my overall research include: (a) Is there evidence that this legislation
positively impacts access to health services for survivors, utilizing VAWA as a baseline for
comparison, (b) how has the ACA impacted service mandates and funding for survivors,
specifically within CHCs, and (c) what is the relationship between the ACA and potential longterm health effects and outcomes of IPV survivors? In crafting an effective research design to
address these questions, it is crucial to recognize that the ACA remains a fairly new piece of
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legislation. Signed into law in 2010 and fully implemented beginning in 2014, the vast majority
of the ACA’s mandates have not yet been in place for a sufficient time period to allow for an
accurate study of long-term implementation implications. As a result, conducting deductive
research in an attempt to prove causality between ACA policies and improved services or health
outcomes for survivors is beyond the present scope of my study. Rather, I acknowledge the
existing limitations that inhibit deductive study quantifying or proving this relationship in such
initial analyses of the ACA’s early impact, and thus specifically map out the relationship
between the ACA’s health policy reforms and IPV survivors through inductive reasoning.
A. Evaluating IPV Legislation and Policy
Exploring this relationship necessitates a deeper understanding of the legislative and
policymaking process. My research design aims to explicate the formulation and evolution of
federal health policy addressing IPV from VAWA to the ACA. This legislative analysis includes
advocate and public health expert input, budget considerations, and federal mandates. I center
my research design on inductive research through the qualitative methods of textual analysis,
case studies, and examination of compiled secondary data. A qualitative research design is
consistent both with the goal of this project in laying out the development and progression
process of IPV policy, and also with the methodology used by existing scholars analyzing federal
responses to this issue. The works of Runge (2013), Oberlander (2016), Sonfield and Pollack
(2013), Boba and Lilley (2009), and others informed my own emulation of their legislative
process tracings. These scholars rely heavily on qualitative, direct textual analysis of public
statutes, as well as legislative histories and government reports, in order to substantiate claims
made in their analysis about a particular policy.
However, each of these scholars uses legislative history research frameworks to analyze
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only one particular piece or aspect of legislation related to IPV, or to provide a very broad policy
overview of statutes. My project diverges from existing research to the extent to which I delve
into to the legislative history of specific sections of multiple laws that pertain to IPV survivor
and health care; both policy researchers and developers heretofore inadequately addressed the
interconnections of this issue. Conducting legislative histories on the most significant bills
addressing violence against women and health policy, coupled with a case study of these bills’
impact on CHCs, constitutes the primary portion of my original data collection. Currently,
scholars Runge (2013) and Modi et al (2014) offer the most comprehensive evaluations of
federal policy aimed at prevention and treatment for violence against women, and Sonfield and
Pollack (2013), as well as other scholars, provide the most updated analyses of the ACA and its
initial implementation effects. However, gaps remain in that no research has yet brought all of
the relevant policies and literatures together to explore this specific relationship. I fill in the gaps
remaining in current scholarship by synthesizing (1) legislative histories, (2) analysis of
government reports and secondary data, and (3) funding allocations for programs in CHCs, to
create a detailed, process-tracing review of healthcare for IPV survivors.
To conduct this analysis of health policy aimed at IPV, I use VAWA 1994 and its
subsequent 2000, 2005, and 2013 reauthorizations as a baseline for comparison of the ACA’s
dictated policies and anticipated effects. As discussed in the Literature Review, state and federal
lawmakers increasingly recognized domestic and sexual violence as a public health problem
following the 1970s push of women’s rights activists and the battered women’s movement
(Runge 2013). However, violence against women largely remained conceptualized as a problem
of the private sphere, rather than as a federal policy priority. There is widespread consensus
among public health, public policy, and women’s rights fields that VAWA 1994 represented the
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first comprehensive piece of major federal legislation drafted specifically to address issues of
gender-based violence (Mitchell and James 2009; Runge 2013). Therefore, my study of the
ACA’s potential changes in domestic violence and sexual violence policy must be grounded in a
process tracing of VAWA’s evolving provisions relating to IPV and health care. As Literature
Review scholarship addresses, VAWA’s original formulation insufficiently addressed IPV’s
health consequences, solely encouraging a stronger criminal justice response. Similarly,
Congress initially reauthorized VAWA as part of the Victims of Trafficking and Violence
Protection Act of 2000, which added initiatives to assist victims of dating violence, elder abuse,
and domestic violence targeted at individuals with disabilities, but did not contain any health
policy provisions or services (Laney 2010; Runge 2013).
It was not until the Violence Against Women and Department of Justice Reauthorization
Act of 2005 that federal legislation expanded support for IPV responses to include collaboration
with health care professionals (Runge 2013). VAWA 2005 represented the most far-reaching
expansion of federal IPV policy, addressing additional forms of violence including domestic
violence, sexual assault, dating violence, stalking, elder abuse, and child abuse and neglect more
effectively	
  than previous legislation (Runge 2013, 438). Based on these factors, as well as the
fact that the 2005 reauthorization was the last version passed prior to the passage of the ACA in
2010, I center my textual analysis principally on programs established under VAWA 1994
through VAWA 2005. My process-tracing legislative history considers VAWA 2013, however,
to the extent that my research question necessitates a complete understanding of how the ACA’s
strategy addressing IPV may differ from policy established under other federal statutes.
Using VAWA as my standard for comparison, I study the ACA in part because of IPV
advocates’ criticism of VAWA as not going far enough to prevent and mitigate IPV. Following
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VAWA, the ACA marks the most significant piece of federal legislation including provisions to
address violence against women. This legislation is valuable to explore in relation to IPV
because of the historic deficiency in legislators and policymakers’ considerations of IPV health
effects. Drawing on existing scholarship, it is clear that both deeper research and further policy
development are required in exploring the relationship between IPV and federal policy beyond
the limited criminal justice lens.
B. Conducting Legislative Histories
I begin my study of evolving federal IPV policy from VAWA to the ACA by collecting
all relevant documents comprised in an official legislative history. Legislative histories include
basic descriptive elements of the law subject to analysis: bill number, Congress number, popular
or common name, significant dates of consideration and passage, related bills, and bill sponsors.
I gather the Congressional Record (CR) index for each law, as well as the Congressional Record
of Debates, committee hearings and reports, and a summary of the enacted public statute.
Government reports and hearings are essential to answering my research question in that they
provide important background, and offer a detailed account of each law’s drafting considerations
and evolution. In particular, committee reports and hearings allow me to see whether IPV was of
special focus, or emphasized, in drafting of policies related to increasing care affordability,
reducing insurance discrimination, and promoting access to services aimed at improving survivor
health outcomes.
Looking at the legislative history of the ACA requires particular attention to the records
of the following committees in both congressional chambers: (a) the Committee on Health,
Education, Labor, and Pensions (b) the Committee on Energy and Commerce Subcommittee on
Health, as well as the (c) House Ways and Means Committee Subcommittee on Health, and (d)
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the Senate Finance Committee. I utilize transcripts of Committee hearings and debates of each
bill, therefore providing context and clarifying questions potentially raised or unresolved by a
reading of solely the actual bill text. Careful examination of committee hearings leading up to the
passage of VAWA and the ACA allows me to understand the meanings of particular provisions
related to IPV, why such provisions were included, and which scholars and factors were
considered by each bills’ sponsors in drafting the legislation. I conduct a latent content analysis
of the committee hearings to examine the implicit motivations for inclusion of relevant
provisions. In particular, I use committee reports and hearings to further understand the extent to
which best practices for IPV survivors informed legislators’ crafting of ACA health policy, ACA
service mandates, and funding allocations to programs and sites potentially most impactful for
survivors, such as CHCs.
To complete this research, I accessed the Congressional Record Index for VAWA and the
ACA through the online records of congress.gov. The Congressional Record (CR) is the official
account of daily legislative activity of each chamber and its committees, Member remarks,
communications from the president, and supporting documents. Congress.gov provides full-text
access to daily CR issues dating from 1995, beginning with the 104th Congress. However, as
VAWA 1994 was passed prior to this date of online records, I additionally use information from
databases outside government-compiled records. I collected the documents and transcripts
necessary to a complete legislative history using UConn library website access to the databases
of HeinOnline and ProQuest Congressional Publications.
After organizing the necessary documents to complete my legislative history analysis, I
search each law for the relevant sections explicitly focused on IPV, domestic violence, or sexual
violence; services for survivors; and funding for these services. I conduct this search through an
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online keyword search of the following terms, identified based on the their utilization in public
health and public policy scholarly literature related to IPV:
a)
b)
c)
d)
e)
f)
g)
h)
i)
j)
k)
l)
m)
n)

“Women”
“Battered women”2
“Violence against women”
“Intimate partner violence”
“Sexual violence”
“Sexual assault”
“Domestic violence”
“Family violence”
“Dating violence”3
“Preventive care services”
“Comprehensive services”
“Community health center”
“Federally qualified health center”
“Community-based services”

In addition, my analysis of each legislative history considers both the “related legislation” listed
in the CR Index, as well as the previously existing legislation amended by passage of each public
act. This latter consideration is particularly significant to reveal the relationship between the
ACA and IPV policy, and how this policy represents a change, and possible improvement, from
preceding policy under VAWA.
C. Case Study: ACA Provisions and Community Health Centers (CHCs)
Using the legislative history as starting point, I delve into a deeper exploration of the
provisions of the ACA, looking at two specific aspects that have the potential to affect health
care of IPV survivors: service mandates, and funding for these services. As the ACA marked an
extremely extensive policy reform by overhauling the health insurance structure, addressing each
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
2	
  Contemporary discourse surrounding IPV primarily uses the term “survivor” in reference to individuals exposed to
IPV. However, prior to the passage of the ACA, legislation and policy debates addressing IPV predominantly
discussed the problem solely as a “women’s issue.” During the period in which VAWA 1994 was drafted and
passed, IPV survivors were therefore commonly referenced as “battered women.” I include the search term “battered
women” in this study to ensure that I identify a comprehensive, exhaustive list of relevant sections of VAWA 1994.
3	
  While I do not focus specifically on dating violence, which is a distinct type of IPV, in the context of this paper,
this term is important to include in searching for relevant sections of VAWA and ACA legislation, as it is often
referenced in conjunction with both safety concerns and health consequences of IPV.

	
  

28	
  

of the numerous changes in services, and assessing the service’s relationship to IPV survivor
health, is beyond the scope and feasibility of present study. To narrow my focus, I look at
changes in services provided, and funding levels for these services for survivors, exclusively in
the context of federally qualified community health centers, or CHCs. Studies of CHC public
health implications show that utilization of primary care is associated with improved receipt of
preventive services and screenings, management of chronic conditions, reduced use of expensive
emergency services, and improved overall general health outcomes (Hatch et al 2016; Iyengar
Sabik 2009; Tiefenthaler et al 2005).
CHCs serve as an exemplary case study to elucidate the relationship between the ACA
and survivors’ access to comprehensive health care, as these sites primary serve the commonly
most underserved and persistently uninsured populations. In fact, the majority of CHCs’ patients
either lack insurance coverage or rely on Medicaid coverage (Adashi et al 2010; Hatch et al
2016). CHCs are also typically embedded within rural communities and under-resourced urban
centers in order to target individuals and families most limited in care options. The majority of
patients treated at CHCs are low-income, women, children, and uninsured: thus, patients
represent the very population targeted by ACA interventions (Adashi et al 2010; Hatch et al
2016; Williams 2016). IPV survivors represent an intersection of these most vulnerable
populations, in that survivors are predominantly women, lower-income, and routinely denied
access to medical care and insurance as a result of negative characterizations of IPV victims. As
a result, CHCs are sites at which the ACA has the most enhanced potential to be impactful in
helping survivors; studying CHCs is fundamental to answer my principle research question. As
an exemplification of the ACA’s aim to intervene on behalf of the underserved, including IPV
survivors, CHCs are tied to important comprehensive services aimed at mitigating IPV. CHCs
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are premised on going beyond primary care to present an accessible, coordinated approach to
healthcare (“About Our Health Centers”). As described by Adashi et al (2010, 2049) and other
public health scholars, CHCs provide a whole-person orientation to care, going beyond basic
emergent care for IPV survivors to address compounding health concerns stemming from
violence exposure.
As the purpose of this study is to examine how the ACA addresses IPV, and whether
there is evidence that the ACA positively impacts survivor health and access to services, it is
necessary to draw upon the writings of IPV advocates to develop a list of the “comprehensive
services” required to fully and effectively address IPV through health policy. Consequently, as I
study CHCs both before and after ACA policy, I explicitly compare the availability and funding
of the following “comprehensive services:”
a)
b)
c)
d)
e)
f)
g)
h)
i)
j)

Primary care and dental services
Behavioral and mental health professionals trained at IPV interventions
Mandated preventive screening policies
Counselors, including counseling on health relationships
Substance abuse programs
Pharmacists
Reproductive healthcare services
Social workers and/or case management
Victim advocacy programs
Referrals to community agencies: shelter services, children’s support programs, legal
assistance, transportation, etc

To be defined as “comprehensive,” the preceding services must be ideally delivered onsite at
CHCs, be both confidential and financially accessible, and must address the intersecting short
and long-term physical, emotional, and psychological health impacts of violence. These
“comprehensive services” must be supported by ongoing training and education for health care
providers, federal guidelines and IPV assessment tools, and safety planning policies.
Most significantly, CHC services for survivors must be evaluated based on whether
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federal funding is allocated to support staffing, training, service implementation, and any other
expansions related to complete IPV health care. In order for the ACA to have a real impact on
survivors and their health, its potential advancements must come in the form of funded mandates,
as opposed to unfunded guidelines; promotion of “comprehensive services” is ineffective
without provisions facilitating their implementation. Unfunded mandates fail to solve existing
health policy problems addressed in the Literature Review; CHCs lack the capacity to effectively
screen for abuse, add additional programs, or hire and train new specialized staff in the absence
of federal funding. As a result, following this paper’s overall examination of CHC services
provided nationwide pre-versus post-ACA passage, I explore the additional factor of whether
services are financially accessible to IPV survivors.
I assess service expansions and funding allocation through textual analysis of the relevant
portions of the ACA regarding CHCs, as well as through government and non-governmental
organization reports, and other secondary data sources. Utilizing internal documents from the
federal government as the crafter of the ACA and the source of its funding, I compile reports
from the Congressional Budget Office (CBO) and the Congressional Research Service (CRS)
detailing areas where the ACA amends previous legislation and impacts CHC budgets. The CBO
is a nonpartisan office that provides budgetary and economic information to inform the
legislative and policy process, including budget projections, cost estimates, analytic reports of
federal spending programs, scorekeeping of legislation, and analysis of federal mandates. CBO
reports prove valuable to my research methods in that they provide an objective description of
ACA economic impact, and funded versus unfunded service mandates. CBO and CRS reports
also advance my research by providing information on the availability and funding of the
previously listed comprehensive services within CHCs, and in describing the budget impact of
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the ACA on CHCs nationwide. Similarly, as a nonpartisan office working to provide policy and
legal analysis to Congress, the CRS serves as a vital resource both in policymaking, and in
informing my understanding of the development of health policy for IPV survivors under both
VAWA and the ACA. I support the CBO and CRS data with reports drafted by the US
Preventive Services Task Force, the Office of Violence Against Women under the U.S.
Department of Justice, as well as the Department of Health and Human Services (HHS). Finally,
I utilize NGO data analysis of CHC services, including the National Women’s Law Center,
Futures Without Violence, the Kaiser Family Foundation, the Guttmacher Institute, and the
Institute for Women’s Policy Research, to supplement the analyses provided by federal reports.
D. Strengths and Limitations
The depth and breadth of both the data that I research, and the sources from which I pull
data, are a significant strength of my research methodology. By beginning with a legislative
history and textual analysis of both bill text and congressional hearings, I go directly to the
source of federal health policy to reveal the factors or frames policymakers considered in their
agenda-setting and policy formulation. As this textual analysis is contextualized within a process
tracing of legislative change from VAWA to the ACA, my study for the first time lays out the
evolution of how IPV is considered and addressed in some of the most major, consequential
pieces of federal legislation of the last three decades. In going beyond solely legislative histories
to additionally analyze secondary data sources, I draw upon both objective analyses, and
analyses conducted by experts in the fields of public health and violence against women,
therefore adding legitimacy to my own interpretations. My research design is thorough in its
inclusion not just of a comparison of accessible services before and after ACA implementation,
but also of an assessment of whether these services are (a) comprehensive, (b) adequately
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address IPV’s negative health effects, and (c) are supported by federal funding to facilitate
implementation.
Despite these strengths, a few potential gaps in my research design represent potential
directions for further research, particularly once the ACA has been implemented for a sufficient
period to permit more causal study. Primarily, my study is limited in its scope to look solely at
the legislative provisions provided by the ACA, rather than additionally considering problems of
implementation of these provisions nationwide. While it may be argued that ACA
implementation varies widely by state, particularly as a result of states differing in their decisions
on Medicaid expansion, the creation of state health insurance exchanges, and the prevalence of
CHC utilization, considerations of implementation are beyond the scope of the present study. As
I explore how the ACA, as written policy, addresses IPV from a health-based perspective, I
purposefully narrow this study to textual analysis. Plus, only eight years after its passage, ACA’s
long-term implementation effects cannot definitively revealed.
In addition, some scholars may criticize my use of funding for services as a factor
explicating the ACA’s impact on survivors. While funded mandates and federal funding
allocations do not necessarily directly correlate to more accessible services or positive health
outcomes, the inclusion of budget considerations in my study advances beyond existing
scholarship. My research represents a significant first step and preliminary articulation of the
relationship between the ACA and IPV; while future research will be able to go further in
understanding ACA implementation and effectiveness, it is important to conduct this early
analysis of the ACA to help shape better policy formulation, and to inform potential
strengthening or reform of existing ACA provisions. The identified potential gaps in the present
study facilitate directions for future inquiry into the long-term health impacts of the ACA on IPV

	
  

33	
  

survivors, the personal experiences of IPV survivors at CHCs under the ACA, and, eventually, a
deductive determination of whether or not the ACA causally marks an improvement from
previous federal health policy.
Data and Results: Legislative Histories of VAWA and the ACA
A. Introduction to Legislative Histories
In this section of the paper, I conduct legislative histories of both VAWA and the ACA,
for purposes of clarifying information relevant to understanding the IPV health care policy
crafted by each statute. Legislative histories are essential to my analysis of the ACA and its
impact on health care access for IPV survivors in that these histories provide context for bill
crafting and passage. Legislative histories act as a compilation of the documents and information
produced by Congress as a bill is drafted, introduced, debated, and considered. Legislative
histories include several types of legal and legislative documents, including committee reports,
committee hearing documents, transcripts of floor debates, and drafts of the bill text, itself
(Legislative History Research Guide, 2016). Committee reports provide important background
and offer a detailed account of bill’s legislative evolution, while hearing documents are
transcripts of actual debates that took place on bills. Both documents serve to clarify questions
raised by reading only the bill text, such as the explicit meanings of a particular provision, and
why it was included. Put simply, a complete legislative history traces the chronological steps the
legislation followed through Congress, and the materials that explain what happened during each
of these steps of the legislative process.
Legislative histories provide vital insight into the background and events leading to the
enactment of a statute. Legislative histories are primarily recorded to aid interpretations of the
legislative process, and the laws the subsequently emerge from this process. Beyond strictly
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textual interpretation, legislative histories allow researchers to discover which committees and
Members were involved in the bill’s passage, how the legislative language evolved or was
amended as it advanced through the congressional process, and how Members voted on both
proposed amendments and on final passage. A complete understanding of the creation of
healthcare-focused statutes, including the potential partisan and policy-based motivations behind
the inclusion of certain language or amendments, will help deepen my analysis of how health
policy for IPV survivors evolved since the passage of VAWA 1994. For the purposes of the
present research focus, I compile and compare legislative histories of relevant sections of
VAWA 19944 and the ACA (2010). For each piece of legislation, I provide a summary of
relevant sections of bill text, thereby establishing information necessary for textual analysis and
comparison of the statutes in the Analysis section of this paper5. This deeper examination of both
VAWA 1994 and the ACA allows me to look at the legislation through a lens of the historical
context at the moment of each respective statute’s drafting. I use a comparison of VAWA and
the ACA’s legislative histories to show that while the ACA primarily aimed to reform the health
care insurance and delivery systems in general, the ACA also much more specifically addressed
the long-term health care needs of IPV survivors than did VAWA 1994.

	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
4	
  As noted in the Background and Literature Review sections, VAWA 1994 requires congressional reauthorization,
resulting in three reauthorizations in 2000 (P.L. 106-386), 2005 (P.L. 109-162), and 2013 (P.L. 113-4). For the scope
of this paper, I primarily discuss VAWA 1994, as this statute serves as the baseline for comparison in understanding
how ACA provisions change, go beyond, and potentially improve upon the VAWA provisions. I additionally
include a succinct analysis of relevant portions of the Violence Against Women and Department of Justice
Reauthorization Act of 2005, as this legislation marked the first time that federal policy targeting violence against
women expanded to include health care-focused provisions. It is beyond the aim of this paper to discuss VAWA
2000, which produced little change from VAWA 1994, or to include an analysis of VAWA 2013, which was passed
after the ACA (2010) and similarly includes few provisions related to IPV and health policy.
5
In conducting legislative histories of these two laws, I use databases of HeinOnline, ProQuest Congressional
Researcher, and the Congressional Research Service. The sources I use include the text of scholarly articles
describing the two specific bills and their implementation, accompanied by scholarly articles process-tracing the
evolution of federal health policy both in general, and specifically in reference to IPV. See the Research Design
section for further detailed explanation of methods employed.
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I begin with a legislative history of VAWA 1994, as this law serves as the baseline for

comparison in understanding how ACA provisions change, go beyond, and potentially improve
upon the VAWA provisions. The legislative histories included in this section provide a general
overview of the major policy provisions and programs established under each law, but place
primary emphasis on the sections of the statutes that specifically reference the forms of family
violence that fall within the definition of IPV. I conducted a complete legislative history of the
VAWA 1994 bill, but for this scope of this work I narrow in on the specific documents most
relevant to advancing my argument. The majority of this section emphasizes VAWA’s treatment
of domestic violence and sexual violence by intimate partners, and the programs and grants
created. By conducting this legislative history, I reiterate the point made in the Literature Review
that VAWA did not address IPV with survivor health outcomes in mind, but rather from a
criminal justice lens.
Next, I conduct a legislative history of the ACA, beginning with a concise overview of the
overall purpose and outcome of the law, followed by a more detailed explanation of the sections
of the statute addressing women’s health, IPV, family violence, and preventative health care.
This includes 12 statute sections that amend VAWA, and that address IPV, CHCs, prevention
tools and comprehensive services, and funding for these services. As the central question of this
thesis centers on how the ACA addresses IPV, this portion makes up the most significant section
of the legislative history component of my research design.
Finally, I conclude the legislative history section of this paper with a textual analysis and
comparison of two main statutes studied: VAWA 1994 and the ACA. An understanding of this
evolution, beginning with VAWA 1994’s criminal justice provisions toward a more preventative,
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health-centered approach to policy allows an analysis of the ACA with an eye to whether the
ACA marks a change and advancement from previous policy.
B. Legislative History of the Violence Against Women Act of 1994 (VAWA)
I. Bill Information and Timeline of Actions
The Violence Against Women Act of 1994 (VAWA) (Title IV, sec. 40001-40703, P.L. 103322) was introduced, considered, and enacted by the 103rd Congress (1993-1994) as part of the
larger Violent Crime Control and Law Enforcement Act of 1994. Rep. Jack B. Brooks (D-TX-9)
introduced the bill, H.R. 3355, on October 26, 1993. H.R. 3355 was cosponsored by Rep.
Charles E. Schumer (D-NY-9) on October 26, 1993, and by Rep. William J. Hughes (D-NJ-2) on
November 11, 1993. The official title of the bill as introduced in the House of Representatives:
To amend the Omnibus Crime Control and Safe Streets Act of 1968 to allow grants to increase
policy presence, to expand and improve cooperative efforts between law enforcement agencies
and members of the community to address crime and disorder problems, and otherwise to
enhance public safety. The popular title for Title IV, the portion of the overall crime bill
addressing IPV, was the Violence Against Women Act of 1994 (VAWA 1994). While VAWA
1994 was part of a much larger, all-encompassing piece of legislation aimed at reducing crime,
this legislative history focuses on the sections of Title IV of H.R. 3355 that advance my
argument. There are no amendments to the VAWA sections of this legislation.
Following its introduction in the House, H.R. 3355 was reported to the House Committee on
the Judiciary and was agreed to by voice vote in the House on November 3, 1993. The Senate
passed H.R. 3355 by a vote of 95-4 on November 19, 1993. The Senate passed this House
version of the Violent Crime Control and Law Enforcement Act in lieu of a related bill, S. 1607,
introduced in the Senate by Senator Joseph R. Biden Jr. (D-DE). A conference committee met in
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June and July of 1994 to resolve differences in Senate and House amendments to the legislation,
resulting in the filing of conference reports H Rept. 103-94 on August 10, 1994 and H Rept. 103711 on August 21, 1994. The conference report was agreed to in the House by a recorded vote of
235-195, and in the Senate by a Yea-Nay vote 61-38. Finally, H.R. 3355 was presented to
President Bill Clinton on September 12, 1994, and signed into Public Law 103-322.
II. Committee Hearings
Prior to consideration on the House and Senate floors, H.R. 3355 was referred to the
House Committee on the Judiciary and the Senate Judiciary Committee. Each respective
committee held several hearings regarding the proposed drafts of the legislation, through which
lawmakers took heed of the policies supported by domestic violence advocates. The House
Committee on the Judiciary Subcommittee on Civil and Constitutional Rights conducted a
hearing on “Crimes of Violence Motivated by Gender” (HRG-1993-JJH-0052) on November 16,
1993. As revealed by its report, this hearing focused on Title III of the overall crime control bill,
to establish a civil rights cause of action for civil suits against persons who commit sexual assault
and other gender-motivated crimes.
Most significant for the purposes of this work was the hearing “Implementation of the
Violence Against Women Act,” held by the Senate Committee on the Judiciary on September 29,
1994, two weeks following the Act’s passage (HRG-1994-SJS-0029). The Senate Judiciary
Committee conducted this hearing to examine VAWA’s implementation process, specifically
focused on service and funding mandates for programs to aid survivors of domestic violence.
During the course of this hearing, lawmakers heard from two panels of witnesses to discuss both
advancements and shortcomings of the newly enacted legislation. The first witness panel offered
perspective on ways of dealing with domestic violence against women, and co-occurring issues
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related to domestic violence victimization. A second witness panel offered a description of
programs serving survivors of domestic abuse and sexual assault in Schuylkill County,
Pennsylvania, as an exemplar case in government supports for survivors. These panels’
arguments are noteworthy in that IPV advocates immediately identified areas for improvement in
the VAWA legislation, including necessity for more all-encompassing support services for
survivors, beyond the criminal justice perspective.
III. Committee Reports
The House Judiciary Committee served as the central committee during drafting and
consideration of Title IV of P.L. 103-322. The House Judiciary Committee issued four key
reports relevant to the purposes of this legislative history. On November 3, 1993, H.Rept. 103324, “Public Safety and Community Policing: “Cops on the Beat” commended the VAWA 1994
bill’s prioritization of a community-coordinated response to IPV. Through this report, the
Committee recommended passage of H.R. 3355 to amend the Omnibus Crime Control and Safe
Streets Act of 1968. Next, H.Rept. 103-395 of November 20, 1993 recommended passage of the
related legislation H.R. 1133 Violence Against Women Act of 1993. Following the passage of
the overall crime bill H.R. 3355 by the House of Representatives, the House Judiciary
Committee issued H.Rept. 103-694 on August 10, 1994. This report, accompanied by H.Rept.
103-711 from August 21, 1994, acts as the conference report on H.R. 3355, reconciling the
differences in definitions and provisions outlined by the House and Senate versions of the bill.
IV. Congressional Record of Debates
The Violent Crime Control and Law Enforcement Act of 1994, including the Title IV
VAWA statute, was debated for 40 minutes on the House floor on November 3, 1993. During
debates on this legislation, members of the Republican caucus argued that the crime bills up for
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consideration did not go far enough, were written in an overly partisan manner, and failed to
impose strict penalties. Rep. Sensebrenner, Jr. (R-WI-9) argued that the proposed anticrime bill’s
measures “do not do anything as their response to the problems that are so touching our
constituents,” including neighborhood safety and domestic abuse (H8718). Rep. Sensebrenner
additionally criticized the bill for including several unfunded mandates; in the absence of robust
anticrime funding, Rep. Sensebrenner argued that the bill’s intended effects would prove
ineffective. To conclude his floor speech, Rep. Sensebrenner made the point that a myriad of
bipartisan proposals purposed to mitigate violence against women were being held up in
committee. The Member argued, “the victims’ rights proposals, they have gone to subcommittee,
I guess to wait for Santa Claus to come down the chimney, because they will be sitting there at
Christmas and New Years, and more victims will not be able to address the court when the
sentence is imposed upon people who have committed crimes against them” (H8719). Following
this debate, subsequent versions of the bill placed greater emphasis on securing victims’
protections and legal assistance, culminating in the form of VAWA passed the next September.
V: Presidential Message and Signing Statement
In his September 13, 1994 Remarks on Signing the Violent Crime Control and Law
Enforcement Act of 1994, President Clinton provided no specific mention or presidential
message on VAWA, or on any of P.L. 103-122’s provisions addressing IPV. Exemplifying how
IPV was not a top priority in the federal government’s drafting of the 1994 crime bill, President
Clinton instead focused strictly on criminal justice measures of supporting law enforcement,
crime reduction, banning assault weapons, and other measures.
VI. Summary of Public Law 103-322
Title IV of the Violent Crime Control and Law Enforcement Act of 1994, commonly
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referred to as the Violence Against Women Act of 1994, was reported out of the House
Committee on the Judiciary and agreed to by voice vote in the House of Representatives on
November 3, 1993. Subsequently, H.R. 3355 passed in the Senate by a vote of 95-4 on
November 19, 1993. VAWA 1994 passed the Senate in lieu of S. 1607, the version of the crime
control bill introduced in the Senate under the 103rd Congress. As enacted, VAWA 1994
incorporated provisions from related legislation, including the proposed H.R. 4092 version of the
Violent Crime Control and Law Enforcement Act of 1994, in addition to bill drafts considered
under the previous Congress.
The Violence Against Women Act of 1994 was enacted to establish a “national response
to the epidemic of violence against women” (Runge et al 2013, 435). At the time of VAWA’s
original drafting and passage in 1994, violence against women was not recognized as an official
crime. VAWA 1994 takes the important step of formally recognizing violence against women as
a national problem. Policymakers in support of VAWA 1994 “hoped the Act would change the
attitudes of people who have traditionally been insensitive to crimes of violence against women
and who view those crimes as less serious than others” (Boba 2009, 169). The legislation created
a definition of “violence against women” that largely reflected the widely held understanding for
domestic violence at the time. The established definition incorporated the federal felony
definition of sexual abuse, and additional language recognized that a majority of perpetrators are
known by their victims, often as their intimate partners. In this way, VAWA marked a departure
from previous conception of sexual assault as occurring only predominantly by “strangers
jumping out of the bushes,” preying on isolated women.
VAWA 1994 was constructed on two overarching goals: (1) to enhance investigations
and prosecutions of violent offenders, and (2) to provide for grant programs to address violence
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against women through a coordinated community response, based largely on law enforcement
(Aday 2015, 8). VAWA 1994 amended existing federal criminal law, intending to provide
additional protections to survivors of domestic violence, sexual assault, and stalking, and to
bolster protections provided under state laws. VAWA 1994 created penalties for interstate
stalking and domestic abuse, strengthened existing penalties for repeat sex offenders, created
new evidentiary rules, and permitted sexual assault survivors to demand that their alleged
assailants be tested for HIV (Laney 2010, 2). The statute required a federal court that convicted
an individual under its provisions to issue a restitution order, granting remedies to survivors
including attorney fees, transportation costs, and, in certain cases, temporary housing and
funding for medical services (Subtitle E, Section 40504). The statute established federal grants to
cover three areas of focus, with investigations and prosecutions receiving the majority of funding
at $1.6 billion over a five year period, accompanied by funding for victim legal services and
violence prevention. This exclusive emphasis on criminal justice services in these funding
mandates establishes a baseline against which to contrast the health policy provisions of the
ACA. Agencies administering these grants include the Office of Justice Programs, the
Department of Justice, the Center for Disease Control and Prevention (CDC), and the Office of
Violence Against Women (OVW) formed under the statute’s directive (Aday 2015, 8).
Title IV, Subtitle A, Chapter 5: “Assistance to Victims of Sexual Assault” marks the first
section of the legislation specifically providing assistance to survivors, as opposed to focusing on
perpetrators of violence. This provision amends the Public Health and Human Services Act to
allow States to use block grant funding for rape prevention and education programs to conduct
educational seminars, operate hotlines, host training programs for professionals, and other efforts
to increase awareness and help prevent sexual assault. Sections 40152 through 40156 outline
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additional mandates for training for law enforcement, and other professionals. For example,
Section 40153 directs the Attorney General to evaluate the manner in which States protect the
confidentiality of communications between IPV survivors and therapists, trained counselors, and
other health professionals.
Title IV, Subtitle B: “Safe Homes for Women Act of 1994” amended the Family
Violence Prevention and Services Act (FVPSA) to authorize the Secretary of HHS to establish a
National Domestic Violence Hotline. Chapter 6 of this section further amends FVPSA to direct
the Secretary of Education to provide grants to nonprofit organizations to establish community
programs on domestic violence. This section is highly significant to understanding both
VAWA’s mission and goals, as well as how the ACA later built upon these goals, by providing
for a coordinated community prevention and intervention response to IPV. This coordinated
response highlighted the need for heightened supports for survivors beyond crisis services
provided in the immediate aftermath of an incidence of violence. The Safe Homes for Women
Act of 1994 functions as a major component of VAWA 1994 by initiating renewed prioritization
of efforts to combat violence against women through commissioned studies aimed at improving
understanding of this complex issue. Chapter 9: Data and Research convened a panel under the
National Academy of Sciences to study IPV and its effects on both individuals and on wider
society. This provision directs states to collect centralized databases on incidence of sexual
violence and domestic violence, and to set forth reporting requirements for such crimes (Sec.
40292). Of most significant note, Section 40293 required the Secretary of HHS to study, and
recommend, health care strategies for reducing incidence of injuries from domestic violence, and
cost of injuries to health care facilities. This section is one of the only measures in the VAWA
1994 statute that attempts to address IPV through a health policy framework. The articulated aim
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of these studies was to increase public awareness and understanding of IPV to support crafting of
more efficient, effective policy under later VAWA reauthorizations. The act authorizes
appropriations for these studies.
Beyond this, the Violence Against Women Improvements measures (Title IV, Subtitle E)
include congressional mandates to consider survivor health effects in criminal trials against
perpetrators of violence. Specifically, Section 40507 leads the Attorney General and the
Secretary of HHS to report to specified congressional committees on the “medical and
psychological basis of ‘battered women’s syndrome’ and the extent to which evidence of such
syndrome has been considered in criminal trials.” Although Section 40507 incorporates the
Department of HHS in federal IPV response, these provisions contrast from the ACA’s health
policy emphasis by considering IPV’s medical consequences only within the context of abuser
sentencing verdicts, rather than in terms of providing aid for survivors. Subtitle F: “National
Stalker and Domestic Violence Reduction,” amends the federal judicial code to provide grants to
state and local governments for the entering of stalking and domestic violence data into national
crime information databases. Section 40609 directs the Attorney General to begin to include data
regarding domestic violence as part of the National Incident-Based Reporting System, and to
report annually to the Congress concerning stalking and domestic violence. Public health
advocates point to the importance of this measure in that, prior to VAWA 1994, lawmakers
neglected to research or study IPV; significantly, from this point forward, IPV entered
congressional attention when crafting future federal policy.
Finally, VAWA 1994 revised previously existing criminal law, including amendments to
the FVPSA requiring grant applications to include a plan to address the needs of underserved
populations. Subtitle B, Chapter 7 additionally provides for the suspension of funding for

	
  

44	
  

grantees which fail to submit an annual performance report. VAWA 1994 goes beyond FVPSA
to provide technical assistance and training to state domestic violence coalitions to establish
special issue resource centers. VAWA 1994 (P.L. 103-322) addresses certain types of violent
crime against women through grant programs to State, local, and tribal governments, as well as
nonprofit organizations and universities, to reduce domestic violence. VAWA 1994 intended to
foster awareness of domestic violence, particularly between intimate partners; the act worked to
develop services for survivors, and to revise the manner in which the criminal justice system
responds to both domestic violence and sex crimes.
To administer and oversee VAWA 1994 provisions, the Office on Violence Against
Women (OVW) was created in 1995 under the Department of Justice. The OVW directs
financial and technical assistance to communities nationwide in developing programs, policies,
and practices aimed at ending IPV. The OVW administers formula-based and discretionary grant
programs established under VAWA, including: (1) Services, Training, Officers, Prosecutors
(STOP) grants, (2) Sexual Assault Services Program (SASP) grants, (3) state coalitions, and (4)
tribal coalitions. OVW additionally oversees the National Domestic Violence Hotline, the
National Sexual Assault Hotline, the National Teen Dating Abuse Helpline, and the National
Victim of Crime Hotline to assist survivors in connecting with comprehensive service providers
(OVW 2016).
C. VAWA Reauthorizations
I. VAWA 1994 Reauthorizations
Title IV of the Violent Crime Control and Law Enforcement Act of 1994 authorized
funding and implementation for VAWA 1994, pending subsequent reauthorization every five
fiscal years. VAWA 1994 and its reauthorizations in 2000, 2005, and 2013 are significant in that
they represent an evolution in thinking about the crimes that constitute violence against women
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and its scope, the impact of violence on different groups of survivors, and how best to address
the effects of this violence (Runge et al 2013, 438). As summarized in “Twenty Years of the
Violence Against Women Act: Dispatches from the Field,” the general shift over the three
iterations of VAWA has been towards:
enhancing services for victims; recognizing sexual assault, dating violence, and stalking
as serious crimes that communities are under-resourced to address; and strengthening
legal protections and civil remedies for all victims, particularly those for whom accessing
safety and justice is harder because of their race, ethnicity, immigration status, age,
disability, sexual orientation, or gender identity” (OVW 2016, 1).
This is particularly important to consider in the context of this paper’s analysis of evolving
federal health policy regarding IPV, showing the legislative process-tracing from strictly
criminal justice services, towards mandates for a broader range of services, culminating in the
health policy framework initiated under recent VAWA reauthorizations, and most strongly
provided under the ACA.
II. The Violence Against Women and Department of Justice Reauthorization Act of 2005
While Congress reauthorized VAWA in 2000 as part of the Victims of Trafficking and
Violence Protection Act of 2000, it was not until the Violence Against Women and Department
of Justice Reauthorization Act of 2005 (VAWA 2005) that Congress began to utilize VAWA to
contribute to federal health policy combating IPV. Rep. F. James Sensenbrenner (R-WI-5)
introduced H.R. 3402, also referred to as the DOJ FY2006-FY2009 Authorization bill, or the
Violence Against Women Act Court Training and Improvements Act of 2005, on July 22, 2005.
Following its introduction in the House, H.R. 3402 was supported by 19 total cosponsors,
including 10 Democrats and nine Republicans. The bill was reported to the House Committee on
the Judiciary on September 22, 2005 (H.Rept. 109-233), and passed the House by yeas and nays
on September 28, 2005. By December 16, 2005, the Senate Judiciary Committee considered the
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reauthorizing legislation, and discharged H.R. 3402 by unanimous consent. The conference
committee met on December 17, 2005, to resolve differences in House and Senate bill versions,
and the House agreed to a Senate amendment by voice vote (CR H12075-12121).
The 109th Congress passed H.R. 3402 into law by a vote of 415-4 in the House of
Representatives, and by unanimous consent in the Senate. President George W. Bush signed
H.R. 3402 into law on January 5, 2006, thereby enacting P.L. 109-162. President Bush issued a
signing statement on January 10, 2006. However, this presidential message did not explicitly
mention the benefits of the VAWA’s reauthorization component of the wider bill, but rather
singularly focused on wider legislation’s provisions enhancing prosecutorial and diplomatic tools
to combat international trafficking. Following implementation, VAWA 2005 was accompanied
by the enactment of P.L. 109-271, introduced to the 109th Congress by Sen. Arlen Specter (RPA) as S. 3693 on July 19, 2006. The official title of the bill as introduced in the Senate was a
“bill to make technical corrections to the Violence Against Women and Department of Justice
Reauthorization Act of 2005.” Senator Joseph R. Biden, Jr. cosponsored the bill. Among other
things, S. 3693 extended appropriations for certain VAWA 1994 programs, expanded the level of
grant funding for community-based programs for survivors of violence, and amended the federal
criminal code’s definitions of “spouse or intimate partner” to be more widely-encompassing.
This “technical corrections” bill passed the Senate without amendment, and by unanimous
consent, on July 19, 2006 (CR S7936-7941). The bill passed the House without objection on July
29, 2006, and was signed into law by President Bush on August 12, 2006.
The overall purpose of VAWA 2005 was to amend VAWA 1994 to revise definitions and
grant conditions, including new requirements for the protection of the confidentiality and privacy
of persons receiving services under the Act. VAWA 2005 appropriated $3.935 billion over five
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fiscal years to continue advancing the goals of 1994, and to tackle issues identified by
implementation of VAWA 1994 and VAWA 2000. Under this statute, the 109th Congress
extended specific protections for immigrants, children, the elderly, pregnant women, and Native
women. The central measures of this reauthorization sought to expand collaboration in
preventing, and responding to, violence to include not only law enforcement and emergency
crisis services professionals as under previous bill versions, but also health care professionals
and youth counselors. VAWA 2005 responded to limitations identified in the original VAWA
statutes by improving targeted funding for prevention through targeted programs aiding
underserved populations with the greatest risk for violence victimization. In addition, VAWA
2005 focused on funding for survivors facing unique challenges and barrier to health care, such
as older survivors, teenagers and college students, and rural and urban communities exhibiting
disproportionate rates of victimization (Runge et al 2013, 437).
Title I: “Enhancing Judicial and Law Enforcement Tools to Combat Violence Against
Women,” reaffirms VAWA’s guiding emphasis on a criminal justice response to IPV, as the
reauthorization places law enforcement methods at the forefront of the legislation. Beginning
with Title II: “Improving Services for Victims of Domestic Violence, Dating Violence, Sexual
Assault, and Stalking, VAWA 2005 dedicates several provisions to advancing long-term support
services for survivors. Section 202 established one example of such services, directing the
Attorney General to provide grant funding to states to establish sexual assault services programs,
including rape crisis centers and “community-based, culturally-specific intervention and related
assistance.” VAWA 2005 also goes beyond previous federal IPV legislation in that it is the first
version of VAWA characterized by a stronger emphasis toward violence prevention measures.
Title IV: “Strengthening America’s Families by Preventing Violence,” sets up grant funding to
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“eligible entities” to mitigate the effects of violence on children and youth, and “to reduce the
risk of future victimization or perpetration of such violence” (Sec. 401). Risk reduction and
prevention grant funding was therefore directed toward home visitation programs, as well as
programs related to engaging men and youth in preventing IPV by “helping them to develop
mutually respectful, nonviolent relationships” (Sec. 401). Sec. 403 of Title IV authorizes
appropriations for state campaigns to increase public awareness of issues regarding domestic
violence and its consequences for pregnant women, in particular.
In examining how the ACA improves upon policies established under VAWA, the most
noteworthy provision of VAWA 2005 is Title V: “Strengthening the Healthcare System’s
Response to Domestic Violence, Dating Violence, Sexual Assault, and Stalking.” Title V amends
the Public Health Service Act to require the Secretary of HHS through the Health Resources and
Services Administration (HRSA), to award grants to schools of medicine funding the
development of interdisciplinary training and education programs. These programs are designed
to provide health professions students with a comprehensive understanding of, and clinical skills
relevant to, IPV. Grant funding must be used to: (1) train health professionals to both identify
and provide health care services to survivors of violence; and (2) to plan and develop “culturally
competent clinical components” to be incorporated into residency training programs, which
address health issues related to IPV (Sec. 503). Such training programs exemplify areas in which
policymakers incorporated public health best practices for IPV response while crafting ACA
legislation. In contrast to VAWA legislation funding, CA funding mandates reflect legislators’
intent to prioritize specialized medical care for survivors, provided by clinicians specifically
trained in trauma-informed, sensitive, confidential treatment techniques. Significantly, Section
504 requires the Secretary of HHS and the CDC Director to award grants to state and local
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entities to improve the response of health care to IPV victimization through “comprehensive
strategies.” Finally, Section 505 authorizes grants to fund research on more effective
interventions in the health care setting that: (1) prevent IPV across the lifespan; (2) prevent the
long-term health consequences of domestic violence, dating violence, and sexual assault; and (3)
advance health and safety of survivors.
D. Legislative History of the Affordable Care Act (ACA) (2010)
Following VAWA 2005, the ACA was the first piece of major federal legislation
containing sections offering targeted solutions to IPV survivors’ needs. Lawmakers and the
Obama administration presented the ACA as a drastic overhaul of federal health policy, and the
U.S. health insurance and health care systems. Understanding the contextual information
described in the ACA’s legislative history, such as insight into policymakers’ intent in crafting
the ACA’s policies, will facilitate deeper evaluation of whether the ACA’s provisions present
more effective services for survivors, beyond the services initially offered by VAWA.
I. Bill Information and Timeline of Action on the Bill
On September 17, 2009, Rep. Charles B. Rangel (D-NY-15) introduced H.R. 3590,6
Patient Protection and Affordable Care Act. 40 legislators cosponsored this bill under the 111th
Congress, including 37 Democrats and 3 Republicans. The official title of the bill, as introduced
in the House, was: to amend the Internal Revenue Code of 1986 to modify the first-time
homebuyers credit in the care of members of the Armed Forces and certain other Federal
employees, and for other purposes. The short title, as introduced in the House, was: the Service
Members Home Ownership Tax Act of 2009. This title evolved to the Patient Protection and
Affordable Care Act, Service Members Home Ownership Tax Act of 2009 by the time of
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  H.R. 4872 also made a number of health-related financing and revenue changes. Read together, H.R. 3590 and the
health care-related provisions of H.R. 4872 are commonly referred to as the Affordable Care Act (ACA).	
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passage in the House of Representatives. In the Senate, the bill that became the ACA was
officially entitled The Patient Protection and Affordable Care Act. During the time of its drafting
and consideration, however, H.R. 3590 was popularly referred to simply as the “health care
reform bill” (CRS 2010). Over 15 related bills accompanied the health care reform bill, including
eight bills introduced in the House of Representatives to address more specific health or tax
credit needs, and seven similar bills introduced in the Senate.
Following its introduction in the House of Representatives, lawmakers added 506
amendments to the bill during the course of congressional hearings, committee consideration,
and floor debate. H.R. 3590 was referred to several committees for more detailed consideration,
including: the House Committee on Health, Education, Labor, and Pensions (HELP Committee);
the House Committee on Energy and Commerce, Subcommittee on Health; the House
Committee on Ways and Means, Subcommittee on Health; and the Senate Finance Committee.
After being reported out of committee, H.R. 3590 was voted on in the House on October 8, 2009
on motion to suspend the rules and pass the bill, agreed by the yeas and nays 416-0 (CR
10/07/2009 H10550). 16 Members did not vote. The Senate later considered the health care
reform bill, voting on December 24, 2009 to pass the bill, with amendments, by a yea-nay vote
of 60-39. Included in the yea votes were 58 Democratic Senators and two Independents;
Republican Senators cast all 39 of the nay votes (CR S13890-14212).
In March of 2010, a conference committee met to resolve differences between the House
and Senate versions of the health care reform bill. The House agreed to Senate amendments to
H.R. 3590 on March 21, 2010, by a recorded vote of 219-212 (Roll no. 165), with the majority of
yea votes cast by Democrats, and most nay votes cast by Republican Members. The Patient
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Protection and Affordable Care Act (ACA) was presented to the President on March 22, 2010.
President Obama signed the ACA into law (P.L. 111-148) on March 23, 2010.
II. Committee Hearings and Reports
In two years prior to the ACA’s enactment in 2010, policymakers proposed and
considered several iterations of the bill that eventually passed into law. During this period,
congressional committees, particularly the HELP Committee and the Committee on Ways and
Means, conducted hundreds of hearings to inform drafting. In the context of this work, one
committee report essential to understanding the ACA’s health policy goals is entitled
“Affordable Health Care for America Act: Meeting Women’s Health Care Needs.” The House
Committees on Ways and Means, Energy and Commerce, and Education and Labor issued this
report on October 29, 2009. It is important to note that this committee report references a
previous version of H.R. 3590, introduced in the prior congressional session under the title
Affordable Health Care for America Act. I single out this committee report for more detailed
analysis in that it illuminates the evolution of health care reform bills under the 111th Congress,
as well as elucidates lawmakers’ intent and thought-processes in crafting the ACA statute.
The report “Meeting Women’s Health Care Needs” acknowledged that under the health
care system in place prior to the ACA, comprehensive health care for women, in general, as
often unavailable, prohibitively expensive, or excluded key services that women need. These
effects were exacerbated for women who are also survivors of violence. Because of this, the
committees proposed several key women’s health provisions for incorporation in health care
reform. Even in crafting this early form of the eventual ACA statute, lawmakers recognized need
to “immediately prohibit plans from discriminating on the basis of domestic violence as a preexisting condition” (1). In addition, the report advocates for maternity and prevention services in
any essential health benefits package, and to make preventive care more affordable by
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eliminating out-of-pocket expenses on recommended preventive services. These “recommended
preventive services” included IPV screenings (“Meeting Women’s Health Care Needs 1). This
committee report therefore directly relates to my guiding research question, in exemplifying how
IPV was considered throughout the ACA’s drafting and evolution.
IV. Presidential Message
Upon signing the ACA into law on March 23, 2010, President Obama issued a signing
statement remarks, emphasizing that the legislation sets in motion “reforms that generations of
Americans have fought for and marched for and hungered to see” (American Presidency Project
2010). In particular, the president’s highlighted the ACA’s coverage extensions for Americans
with preexisting conditions, requirements for free preventive care, and creation of health
insurance exchanges increasing widespread access to affordable, quality insurance. President
Obama’s remarks also thanked the tireless efforts of Speaker of the House Nancy Pelosi, Senate
Majority Leader Harry Reid, Secretary of HHS Kathleen Sebelius, White House official NancyAnn DeParle, and the numerous advocates who fought to make the legislative vision of equitable
health care into reality. President Obama lauded the ACA for enshrining “the core principle that
everybody should have some basic security when it comes to their health care,” and for
extending protections to populations with heightened health risks (American Presidency Project,
2010). Although President Obama did not overtly reference the ACA’s beneficial impact on IPV
survivors, the weight placed on accessibility and prevention in this signing statement indicates
the Obama administration’s emphasis on sections of the legislation most impactful for IPV
survivors.
In addition, immediately after President Obama signed the ACA into law, Former White
House Advisor on Violence Against Women, Lynn Rosenthal, published a post reflecting the
White House’s position on the new legislation. Entitled, “For Victims of Domestic Violence,
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Health Care is a Lifeline,” Rosenthal articulated one of the central aims of the federal
government in passing the ACA: to “help domestic violence victims get the health care they
need.” This published post is one of the earliest official government publications recognizing the
impact of the ACA on IPV survivor health, noting, “For all women, the advent of health care
reform is a victory. For domestic violence victims, it is a lifeline” (Rosenthal 2010). By
discussing the ACA’s importance in ensuring that survivors do not have to worry about access to
care, this post implicitly acknowledges the shortcomings of existing VAWA legislation, and
highlights the necessity for a greater, intentional focus on women, and IPV survivors in
particular, in drafting any health care reform policy. Rosenthal’s post is significant in
understanding the position of the Obama administration in advocating for this legislation, and
particularly in highlighting the emphasis placed specifically on expanding access to
comprehensive care for IPV survivors, beyond the care provided under existing federal IPV
policy. Rosenthal’s statement therefore further reiterates the congressional and White House
intent in drafting the ACA, and in including provisions targeting IPV through service and
funding mandates.
VI. Summary of Public Law 111-148
As the ACA sparked an extremely vast, wide-ranging reform of the entire U.S. health
care system and health insurance markets, an overview summarizing the entirety of the ACA’s
provisions is far beyond the scope of this paper. As explained in the Research Design, I primarily
examine the ACA in comparison to the baseline provisions established under VAWA, therefore
this summary narrows in on the portions of the ACA statute most pertinent to women’s health
care and, more specifically, service and funding mandates for IPV survivors. The described
relevant sections were identified as explained in the Research Design. As I subsequently focus
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on the case study of services available to survivors at CHC sites, this summary additionally
explicates sections of the ACA establishing grant funding for these CHCs.
The overall aim of the ACA, as expressed in Title I: “Quality, Affordable Health Care for
All Americans,” was to introduce new regulations for the insurance industry to facilitate access
to insurance coverage, and to prevent insurance discrimination. The ACA was specifically
designed to address disparities in access to quality health care services (Atsas and Kunz 2014,
409). In this way, the ACA has the potential to prove critically impactful for IPV survivors by
increasing the number of survivors with insurance coverage, increasing the value of insurance
coverage for addressing IPV-related health effects and reproductive health, as well as facilitating
access to reproductive health services (Sonfield et al 2013). By drastically expanding the ability
to purchase insurance, the ACA permits countless survivors to gain entry into a health system
previously barred to them; this is an extremely important point in that the health care system
serves as the entry point for many survivors in reporting violence and accessing care (Stolp and
Fox 2015, 878).
Title I, Subtitle A “Immediate health Improvements in Health Care Coverage for All
Americans” signifies a major reform in federal health policy by requiring health plans to provide
coverage, without cost-sharing, for: (1) general preventive services; (2) recommended
immunizations; and (3) recommended preventive care and screenings for women and children.
While previous health policy, in addition to federal IPV policy, were based on more reactionary
measures to health issues, this emphasis on preventive services in the opening section of the
ACA highlights the centrality of prevention and risk reduction under the reform legislation. As
expressed by Futures Without Violence, the ACA’s mandates promoting preventive care reflect
the goal of “injury and violence free living” as one of the seven national health policy priorities
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implemented under the ACA’s reforms (2012, 3). For the first time, policymakers included
violence prevention, including IPV risk reduction, as a central aim of health legislation.
Title I additionally establishes access to quality health insurance coverage for all
Americans through health insurance market reforms, and establishment of quality health plans.
Subtitle C, Part I, prohibits health plans from imposing any preexisting condition exclusion, or
from discriminating on the basis of any health status-related factor (Section 1201). Section
1201’s health insurance market reforms thus prove crucial to expanding IPV survivor’s access to
care, as insurance plans can no longer deny survivors,7 or charge higher premium rates, based
upon previous exposure to violence. Most notably, Subtitle D “Available Coverage Choices for
All Americans” created requirements for health plans to cover “essential health benefits”
(Section 1302). The ACA defines these essential health benefits (EHBs) to include “emergency
services, hospitalization, maternity and newborn care, mental health and substance use disorder
services, prescription drugs, preventive and wellness services and chronic disease management,
and pediatric services” (Section 1302). The act directs the newly established U.S. Preventive
Services Task Force (USPSTF) (Section 4104) to study and recommend a list of comprehensive
“preventive and wellness services” for inclusion under these EHBs. Following this mandate upon
ACA implementation, the USPSTF made recommendations for preventive services based on
criteria including: (1) that the service’s targeted condition affects a broad population, (2)
scientific evidence supports the recommendation, and (3) the advocated intervention has
potential to improve health or well-being “significantly” (Stolp and Fox 2015). As a result, the
USPSTF advised coverage of: vaccinations; interventions to facilitate breastfeeding; screenings
for STIs, and for certain cancers; preventive care for minors, including counseling and
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
7	
  Prior to the enactment of Section 1201 of the ACA, domestic violence and sexual assault survivors could be
denied health insurance, as violence victimization could be considered a “pre-existing condition.” As a result, over
65 million women were denied insurance coverage prior to 2010 (Nicelli 2017, 3). 	
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reproductive health issues; annual well-woman visits; expanded services for pregnant women;
and, most critical to the focus of this legislative analysis, screening and counseling for IPV
(Sonfield et al 2013; U.S.C. 42 U.S.C. 18001). In this way, the ACA vastly advances the
definition of basic health care to provide for coverage of key services for women, and for
violence prevention.
The ACA also prioritizes women’s health care and prevention services through Title III:
“Improving the Quality and Efficiency of Health Care.” For example, Subtitle C requires
Medicare Advantage plans to apply the full amount of rebates, bonuses, and supplemental
premiums for reduction of cost sharing, and for coverage of preventive care and wellness
benefits (Section 3202). Subtitle F: “Health Care Quality Improvements” specifically establishes
an Office on Women’s Health within the Office of the Secretary, the Office of the Director of the
CDC, the Office of the AHRQ Direction, the Office of the Administrator of the HRSA, and the
Office of the Commissioner of Food and Drugs (Section 3509). The Act also authorized
appropriations for all such Offices on Women’s Health for FY 2010-FY2014. The ACA creates
each of these respective offices to provide for a designated office specifically enforcing the
ACA’s provisions under the framework of providing services for underserved, at-risk women.
Building upon these measures, Title IV centers on “Prevention of Chronic Disease and
Improving Public Health.” In particular, Subtitle A: “Modernizing Disease Prevention and Public
Health Systems” exemplifies areas in which the ACA goes beyond prior health policy mandates
to institute prevention, including violence prevention, as the principal national health care
strategy. Subtitle A requires the President to: (1) establish the National Prevention, Health
Promotion and Public Health Council; (2) create the Advisory Group on Prevention, Health
Promotion, and Integrative Public Health; and (3) appoint the Surgeon General as Chairperson of
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the Council in order to develop a national prevention, health promotion, and public health
strategy (Section 4001). The ACA mandates funding for preventive care through the formation
of a Prevention and Public Health Fund (Section 4002). Plus, Section 4003 compels the Director
of the CDC to convene an independent Community Preventive Services Task Force to review
scientific evidence related to the effectiveness, appropriateness, and cost-effectiveness of
community prevention intervention, purposed to develop recommendations for policymakers.
Related to this measure, Title IV, Subtitle B “Increasing Access to Clinical Preventive Services”
amends the Social Security Act Title XVII8 to provide coverage of personalized prevention plan
services for individuals, and prohibits cost-sharing of such services (Sections 4103-4104). These
measures are significant to my overall research question in that they represent major distinctions,
and expansions, from VAWA legislation’s treatment of IPV survivors. Title IV provisions
demonstrate the ways in which federal IPV response evolved from reactionary efforts that
largely neglected IPV’s health consequences, towards a more preventive focus aimed at reducing
IPV and devastating personal and public health impact.
In order to implement the listed preventive care measures, Title IV, Subtitle C: “Creating
Healthier Communities” mandates grant funding to state and local agencies, and communitybased organizations, for implementation and dissemination of “evidence-based community
preventive health activities” (Section 4201). Plus, of particular importance to this study’s focus
on IPV survivors, Subtitle C, Section 4206 establishes a “pilot program” to test the impact of
providing individualized wellness and prevention plans to at-risk populations who utilize CHCs.
The aim of such wellness plans is to reduce risk factors for preventable conditions, including IPV
and its detrimental health effects, as identified by a comprehensive risk-factor assessment. In
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  This title establishes the program commonly referred to as Medicare.	
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support of prevention and wellness plans, Subtitle D: “Support for Prevention and Public Health
Innovation,” provides funding for federally conducted research regarding health disparities
within at-risk and medically underserved populations (Section 4302).
The ACA supports underserved populations, including IPV survivors, through funding
both for training of health care professionals, as well as for CHCs. For instance, Title V, Subtitle
D: “Enhancing Health Care Workforce Education and Training” awards grants to promote
positive health behaviors and outcomes for populations in medically underserved communities,
using community health workers (Section 5313). Title V provides supports for the existing health
care workforce through grants to educate primary care providers about preventive medicine,
chronic disease and violence reduction management, and mental and behavioral health services
(Section 5405). Subtitle D thus considerably contributes to the ACA’s advancement of services
for survivors, in that such training grants recognize and encompass the necessity of health
provider trainings in meeting the definition of truly “comprehensive services” established in the
Literature Review and Research Design. Plus, of extreme importance to my case study regarding
services accessible at CHCs, Subtitle G: “Improving Access to Health Care Services” centers on
authorizing appropriations for health centers to service medically underserved populations
(Section 5601). Coupled with Title X, Section 103333, this section amends the Public Health
Service Act to authorize grants to support community-based collaborative care networks for lowincome populations. Lastly, Title X, Subtitle E, Section 10503 establishes a Community Health
Center Fund to provide for sustained national investment in CHCs, and prioritization of the
health needs of populations utilizing CHC services.
Discussion and Analysis: Comparing VAWA and the ACA
Both drafted to address needs of underserved and vulnerable populations, VAWA and the
ACA drastically differ in their primary goals, and the lens applied to IPV survivors and
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victimization. Though VAWA legislation effectively introduced IPV into the realm of public
attention and national policy priorities, it falls short in very narrowly addressing survivors’
needs. With IPV generating a huge national health crisis, representing the most common cause of
injury for American women, this violence must be prioritized in federal health policy. To answer
my central research question concerning the extent to which the ACA improves health services
for survivors beyond prior legislation, it is imperative to analyze the ACA’s provisions in
relation to VAWA’s service and funding mandates.
A. Limitations of VAWA
Arguably, the VAWA statutes fostered greater awareness and recognition of IPV as a
national public health issue, and took key steps towards protecting the safety and health of
survivors. Largely as a result of VAWA’s provisions, the rate of IPV against female survivors
declined 53 percent between 1993 and 2008, from 9.4 victimizations per 1,000 females over 12
years of age, to an average of 4.3 victimizations per 1,000 females (Modi et al 2013). According
to the Bureau of Justice Statistics, the rates of violence against males also declined by 54 percent
during this period. Plus, a University of Kentucky report showed a 51 percent increase in
reporting after the passage of VAWA, an over 60 percent decrease in nonfatal violence, and a 24
percent decrease in fatal IPV (Modi et al 254). The Office on Violence Against Women (OVW),
created under the Department of Justice to administer VAWA provisions, also issued a 2016
report analyzing the improvements in federal IPV policy implemented in the period since
VAWA’s implementation. OVW noted the greater coordination among systems and
collaboration across disciplines; maximization of the limited funding available for core victim
services like housing and legal assistance; combatting misinformation, bias, and victim-blaming
attitudes in both public and lawmakers’ understanding of IPV; and enactment of trauma-
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informed service models and trainings (OVW 2016, 16).
Despite these important improvements, by the time of the ACA’s drafting in 2010, IPV
remained an extremely prevalent public health issue; the 2010 National Intimate Partner and
Sexual Violence Survey reported between 1.3 and 5.3 million U.S. women experience physical
violence, sexual violence, or psychological aggression each year (Modi et al 253). Each
subsequent reauthorization of VAWA expanded the definition of violence addressed, as well as
the scope of protections extended to survivors, yet public health scholars and healthcare
professionals identified several areas of greater need. Prior to the ACA’s drafting, however, few
scholars examined VAWA’s shortcomings, or the need for additional federal legislation targeting
IPV’s health consequences, in a truly comprehensive manner. VAWA fell short in creating
systems-level change, and “potentially one of the largest shortcomings of VAWA is the lack of
any comprehensive evaluation of the legislation,” resulting in “complacency, as opposed to
continued reform” (Aday 2015, 19). In contrast to the ACA, which predominantly addresses
survivors’ needs through promoting accessibility of health care and insurance coverage, VAWA
1994 most directly aided survivors by offering solutions to short-term, crisis-based interventions,
as well as housing needs. As articulated by Runge et al, funding for emergency shelters for
“battered women” formed “the backbone of the service provider community for victims at the
time” of VAWA’s passage (445). However, VAWA’s shelter funding provided only a temporary
solution to the instability and health consequences inflicted by IPV; this funding proved
insufficient in promoting long-term safety, stability, and therefore positive health outcomes for
survivors.
Through examining VAWA’s legislative history, coupled with academic and government
analyses of the legislation’s mission and goals, it becomes clear that federal response to IPV
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slowly progressed from addressing solely the immediate legal needs of survivors, towards
meeting the long-term needs to empower survivors to live free from violence (Runge et al 2013,
456). Despite this evolution, several vital provisions were excluded from both the VAWA 1994
statute, as well as its subsequent reauthorizations. For example, noticeably absent from VAWA
legislation are economic remedies for survivors, including access to housing, employment, and
insurance protections (Runge et al 2013, 453). While VAWA 2000 did authorize a study on
health insurance discrimination against survivors, subsequent reauthorizations of the statute
failed to include strong protections for health care services or antidiscrimination in insurance
coverage. In fact, during the legislative sessions in which VAWA 2000 and 2005 were
considered, provisions for such measures constituted part of early drafts or were introduced as
part of the original bill, but were left out of the final versions that passed. In spite of such efforts
to increase the economic and health care focus of federal IPV response, it was not until the
ACA’s passage that federal legislation officially included provisions directly addressing
survivors’ complex health needs. Plus, VAWA insufficiently provides for specialized training for
many officials tasked with promoting the long-term safety and security of IPV survivors. For
example, VAWA training funds are predominantly allocated to law enforcement officers and
exclude countless other officials that may interact with survivors. Beyond this, funds are limited
in providing only for one-time, ad hoc trainings that largely fail to establish a trauma-sensitive
care protocol. Several studies note that gaps in service often arise because officials lack the
expertise to efficiently and effectively deliver a given service mandated under VAWA, as it
relates to IPV or gender-based violence (2015, 15).
Through its 2016 study on the VAWA’s effectiveness in the 20 years following its
enactment, OVW identified key areas of potential improvement to VAWA legislation to enhance
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services provided beyond the criminal justice response. Alarmingly, none of VAWA’s
reauthorizations fully provided for the basic needs of all survivors for “food, shelter, health, and
safety” (OVW 2016, 16). Plus, OVW’s report highlights VAWA’s inability to address the
intersections among complex trauma, multiple victimizations, mental health and substance
abuse, and poverty common among IPV survivors. OVW elucidates one of the most significant
shortcomings of VAWA by arguing for a refocus of federal policy towards preventing violence,
not just through risk reduction as under VAWA’s reauthorizations, but through eliminating its
root causes. Lastly, to improve federal IPV response beyond VAWA provisions, the OVW report
encouraged policies to help survivors pursue alternative paths to safety, other than the criminal
justice system and shelter services (16). Lawmakers worked to address a myriad of these
limitations, particularly through funding for more comprehensive services, in formulating health
care reform policy under the ACA.
B. Distinctions Between VAWA and the ACA’s Approach to IPV Survivors
VAWA and the ACA are comparable in their treatment of IPV only in the sense that both
pieces of legislation primarily approach survivors’ needs through grant funding to public or
private community-based programs, as opposed to through direct provision of services (Aday
2015, 6). During the drafting of the ACA, the advocacy of IPV survivors and public health
scholars elucidated to lawmakers the detriments of VAWA’s narrow criminal justice focus, and
the lack of emphasis on violence prevention. Problematically, VAWA legislation does not
specifically target funds to areas with the greatest need, such as communities with the highest
rates of IPV victimization (Tielfenthaler et al 2005, 566). Even after the federal government
became more directly involved in the funding of programs to assist IPV survivors via VAWA,
existing agencies expanded their offerings, but the number of programs did not increase
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significantly. In this way, VAWA did not go far enough in expanding access to services, as
shown by the mere two percent increase in available programs between the 1994 passage and the
2000 reauthorization of VAWA funding (Tielfenthaler et al 2005, 576).
In evaluating VAWA’s success towards mitigating IPV and its effects on survivors,
scholars agree that one of the greatest advantages of the Act is its promotion of partnerships
between sectors. For example, the long-term goal of the STOP grant program is to “promote
institutionalized system change through communities that results in supportive and effective
responses from the criminal justice and civil justice systems, and other community agencies such
as domestic violence and sexual assault programs (Aday 2015, 13). Public health studies suggest
that the institutionalization of efforts for a community-coordinated response has led to a decrease
in total victimization, and a decrease in repeat offenders. Under VAWA, not only are law
enforcement agencies better equipped to prosecute offenders, but survivors are also empowered
and supported through social service agencies and domestic violence shelters, thereby decreasing
the likelihood that survivors will return to violent partners. While this marks a success for
VAWA in efforts to reach its overarching goals, this example also shows the fundamental
importance of implementing not just a criminal justice response to violence, but also a
comprehensive, community-centered response. Analyzing the effectiveness of communitycoordinated responses to violence highlights the need for, and advantages of, a heightened social
service and health care response to violence. While VAWA falls short in meeting this need, the
ACA is explicitly purposed at implementing a health care response.
As a result of VAWA’s identified shortcomings, the ACA’s legislative history reveals
how lawmakers sought to make IPV a greater priority in federal health policy reform. In contrast
to VAWA’s approach, the two primary methods through which the ACA affects IPV survivors
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include: (1) supporting routine screening and counseling for IPV, including at primary care and
annual well-woman visits; and (2) inclusion of domestic violence in the National Prevention
Strategy (Futures Without Violence 2012, 3). This is distinctive from the driving mission, goals,
and methods of the VAWA legislation in its support for IPV survivors. While VAWA is
administered by the OVW under the Department of Justice, thereby reiterating the central law
enforcement response under VAWA, policy under ACA markedly differs in that the HRSA, the
CDC, and the Secretary of HHS oversee its implementation. This is a notable distinction in that
the agencies administering each law serve as key indicators of the central purposes of the law’s
provisions, as revealed by the lens with which experts in each respective agency view, and
tackle, IPV.
As explained by Futures Without Violence (2012), the “Congressional intent under the
ACA was that screening and assessing for domestic violence can be considered a primary
prevention or early intervention service, similar to obesity screening, smoking cessation, and
alcohol misuse, which is already covered by providers” (1). Overall, the principles through
which the ACA views, and treats, IPV survivors vary greatly from the guiding intent of VAWA
in a manner that supports survivor short-term and long-term health. The ACA’s “lasting impact
is its attempt to move the health system from a disease treatment model to prevention and health
promotion” (Futures Without Violence 2012, 3). One provision central to this aim is the ACA’s
support for services, and funding mandates, for CHCs.
Discussion and Analysis: Examining the Case Study of CHCs under the ACA
A. CHC Funding under the ACA
As previously explained in the Literature Review and Research Design sections, CHCs
represent sites in which the ACA has the opportunity to be particularly and immediately
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impactful in promoting services, and positive health outcomes, for IPV survivors. While the
ACA insurance coverage expansions independently represent a significant step towards
improving accessibility of health care services, “increased coverage may be of limited benefit if
there are not enough places where patients can obtain care” (Han et al 2017). Therefore, CHCs
“play a key role in implementation of the Affordable Care Act” (HRSA 2012, 1) by acting as the
predominant sites through which newly-insured Americans can access health services.
CHCs have a long history of supporting health outcomes of Americans facing the greatest
levels of need. The first CHC opened in 1965 under the direction of the Office of Economic
Opportunity, as a major component of President Lyndon B. Johnson’s War on Poverty initiative
(Adashi et al). CHCs were founded on the guiding mission of reducing or eliminating health
disparities that affected racial and ethnic minority groups, the poor, and the uninsured. The
health center model that emerged, as advocated for by community health and civil rights
activists, targeted the roots of poverty by combining the resources of local communities with
federal funds to establish neighborhood clinics (“About Our Health Centers”). As of 2015, CHCs
served one in three minority patients who fell below the federal poverty line, and one in seven of
all US rural residents; these are the proximate patients most disadvantaged, and most lacking
IPV treatment methods (Proser et al 2015, 50). The CHC model also overcomes geographic,
cultural, linguistic, and other barriers through a collaborative-based approach to care. This teambased system includes physicians, nurses, dental providers, midwives, behavioral health care
providers, social workers, health educators, and many others (HRSA 2012, 2). In this way, CHCs
were designed to constitute a key component of the federal public safety net.
CHCs recognize, and build upon, the link between multidisciplinary healthcare teams and
improved patient outcomes, reduced disparities, and lower costs. It is widely recognized by
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public health and IPV advocates that the unique model of care delivery through CHCs uses
multiple primary team members with varied skills to increase capacity, reduce barriers to care,
and even control the costs of care (Proser et al 2015, 49). In fact, CHCs save the healthcare
system an average of $24 billion annually by reducing the use of emergency departments and
inpatient care for preventable conditions, including many of the long-term side effects of IPV.
While CHCs were well established prior to the ACA, the ACA significantly augmented
health center funding. The ACA, as passed in 2010, established the Community Health Center
Fund, providing a total of $11 billion in federal funding over a five-year period for “operation,
expansion, and construction of health centers throughout the nation” (HRSA 2012). This funding
included $9.5 billion to support ongoing health center operations, to create new CHCs in
medically underserved areas, and--most relevant to the focus of this paper--to expand preventive
and primary health care services at existing sites. Federal grant funding is essential to support
health centers; as of 2015, these grants provided close to 20 percent of health center revenues
(Paradise et al 2017). The Medicare Access and CHIP Reauthorization Act of 2015 further
expanded this funding for 2016 and 2017 (Han et al 2017, 49). This two year extension of critical
mandatory funding for CHCs, as well as for the National Health Service Corps, stabilized federal
funding. In total, over 70 percent of federal health center funding is provided by the health center
trust fund set up by the ACA; without the ACA, federal funding for CHCs would be deficient
(Paradise et al 2017).
B. Impact of ACA Funding for CHCs: Growth in CHC Capacity, Utilization, and Funding
for “Comprehensive Services”
Recent research indicates that CHCs are characterized as particularly responsive during
periods of insurance expansion, such as during Medicaid expansion and the ACA
implementation period. This becomes clearly evident when examining the ACA expansion’s

	
  

67	
  

effects on CHC capacity and utilization. Notably, every additional million dollars in federal
grants for CHCs is associated with capacity to serve about 8,000 more patients per center (Han et
al 2017, 53). As a result, CHC capacity drastically increased in the period following ACA
implementation. While CHCs served approximately 19.5 million patients in 2010, prior to the
ACA’s provisions taking effect, these centers provided care for over 24 million patients. (NPR
2015). This represents about one in 12 U.S. residents; nearly 60 percent of those treated at CHCs
were women, particularly women with high likelihood of exposure to violence (Paradise et al
2017). The ACA underwrites CHCs, and was predicted to enable the centers to serve nearly 20
million new patients, and to add 15,000 providers to staffs, by the year 2015 (Adashi et al). As of
2014, it was predicted that the ACA’s coverage expansions and grants will allow CHCs to serve
a total of approximately 40 million patients between 2010 and 2019 (Atsas and Kunz 2014, 417).
As of 2017, CHCs serve as the primary medical service provider for over 27 million people in
over 10,400 rural and urban communities across the United States.
Increased CHC capacity, and subsequently heightened CHC service utilization, are
directly linked to improved connections to care for IPV survivors. By helping survivors to afford
services, and by expanding the ability of CHCs to provide additional services, the ACA opens a
channel of communication, and potential intervention, between patients experiencing violence
and their health care providers. This marks a significant step in IPV prevention and intervention;
women who have the opportunity to speak with a healthcare provider about abuse are four times
more likely to use intervention, and are over two and a half times more likely to exit an abusive
relationship (Paradise et al 2017, 34). Access to greater intervention in this manner makes a huge
impact on survivors’ health outcomes.
Interviews with clinic directors, IPV advocates, and CHC staff emphasize that the ACA
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has been a “game changer” for clinics, particularly in that CHCs can receive reimbursement for
much more of the care provided to patients. The health center patient population is increasingly
insured, with 76 percent of patients insured by 2015, compared to 65 percent in 2013. This
increase in coverage directly coincided with implementation of ACA service expansions
beginning on January 1, 2014 (Futures Without Violence 2017, 3).
CHC expansion directly relies on having reliable, long-term revenue; the Community
Health Center Fund established under the ACA is what provides this vital funding source. CHCs’
total revenues grew from $15.9 billion in 2013, to over $21 billion by 2015 due to increases in
patient revenues and federal funding under the ACA’s bolstering of Section 330 grants. The
necessity of CHC funding via ACA provisions, and the potential detriment to survivors’ health in
the case of an ACA repeal measure, becomes apparent in examining the effects of temporary
lapse in CHC federal funds in the fall of 2017. The ACA’s Community Health Center Fund
expired on September 30, 2017, and funding provisions were not renewed until February 2,
2018. During this period of lapsed revenue, CHCs’ ability to offer vital services to IPV
survivors, and to all patients, was considerably diminished. The Kaiser Family Foundation
surveyed health centers amidst the fall funding deficiencies, revealing that without grants
secured under the ACA, CHCs reported a marked disruption in care provided. For example, twothirds of CHCs reported instituting a hiring freeze, and 57 percent said they would need to lay off
staff in the absence of federal funding for service mandates. In addition, 60 percent of CHCs
surveyed reported cancelling or delaying new projects and investments, such as building
expansions and advanced training for staff. Finally, nearly 40 percent of CHCs included in the
study said that they were considering severely reducing, and even eliminating, mental health
services offered.
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This is extremely detrimental to both the short-term and long-term health outcomes of

IPV survivors, in that survivors still face continued exposure to violence, and repeated
victimization, even in the absence of support services that work to mitigate the impact of such
violence. Plus, the care disruptions and cutbacks reported by CHCs as a result of the lapse in
federal funding effectively cancel out the positive impact of the exact services that the ACA
implemented or expanded. The negative consequences of this funding lapse further support the
point that support the ACA’s funding for CHCs is foundational to accessibility of services for
IPV survivors; when CHCs face decreased funding, and therefore decreased capacity, the very
services most in need for survivors are those that are likely eliminated first.
Plus, academic and nonprofit-based studies reveal that investment made in health centers
clearly translated to an increase in the types of services available to patients. Han et al (2017)
found that mental health services are particularly responsive to increases in federal grant dollars.
This is extremely significant for IPV survivors in promoting availability of the very services
most necessary for long-term positive health, yet the least available and funded prior to the
ACA’s provisions. Federal funding grants enable CHCs to finance care for uninsured patients,
subsidize insured patients, and finance services not covered by insurance. For example, ACA
Section 330 grant funding enables services not covered by most basic insurance plans, including
adult dental, transportation to care providers, and translation services. In addition, grant funding
expands CHCs’ capacity for care management, and even to use sliding fees for privately insured
patients who cannot afford deductibles and copays (Paradise et al 2017, 6). IPV survivors
depend upon these program and funding mandates in that survivors are often burdened with high
health care costs, and with several co-occurring health issues perpetuated by violence
victimization. Plus, IPV survivors are at risk for repeated future victimization in that many are
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financially dependent on their intimate partners, and cannot afford to separate from their
partners, or to seek treatment, in the absence of CHC grant funding. The Kaiser Family
Foundation report explicitly argues that the “significant improvement in the ability of uninsured
patients to access medical care may be the result of efforts by health centers to expand their
capacity with funding made available by the ACA” (Kaiser Family Foundation 2018).
Grant funding for CHCs under the ACA has additionally proved impactful for IPV
survivors in expand the types of comprehensive services offered to survivors at CHCs, namely
mental health services. In 2016, the Kaiser Family Foundation reported over 104 million patient
visits to CHCs. Of these visits, 68 percent were medical care visits, and nearly 10 percent were
mental health and substance abuse disorder services. Also important to note was the fact that six
percent of visits resulted in assistance to enable access to other necessary care services beyond
those available through the particular CHC, itself (Kaiser Family Foundation 2018). Most
significantly, the report “Community Health Centers: Growing Importance in a Changing Health
Care System” describes changes in CHC services available between 2010, prior to ACA
implementation, and 2016.
One of the most necessary, but often under-provided, services for IPV survivors is mental
health treatment; the ACA works to recognize mental health treatment as of equal necessity with
emergency services or primary care, particularly when treating IPC survivors who may
experience mental health issues like PTSD. While only 73 percent of CHCs offered mental
health care services prior to the ACA, this number rose to 87 percent by 2016. This substantial
increase in mental health service availability exemplifies the ACA’s positive impact on CHC
capacity for “comprehensive services,” and promotes mental health care as a standard form of
care. Similarly, in 2010 only one-fifth of CHCs offered substance abuse disorder services, while
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by 2016 nearly 30 percent of health centers employ dedicated staff for disorder treatment.
Neither of these forms of services was accessible, or even offered, for survivors under the
provisions constituting services for survivors under VAWA.
Conclusion
A. Summary, Discussion, and Conclusions
Attempts to update, and improve upon, federal health policy for IPV must be evaluated
based on the extent to which they provide institutionalized support to promote access to care not
just in theory, but in practice. Through this detailed examination of the legislative histories and
policy outcomes of both VAWA and the ACA, I aimed to analyze the degree to which the ACA
met this standard, and improved upon VAWA provisions for IPV survivors. My findings support
public health scholars’ claims that the ACA does improve upon VAWA’s policies in its shift
from the criminal justice and law enforcement response, to identifying the health care needs to
survivors. The ACA is particularly impactful in shifting emphasis from reactionary legal
measures to preventive health care efforts, and in ensuring that survivors have access to
preventive screenings, emergency, services, primary care, and other comprehensive services
through a network of CHCs. Not only does the ACA provide mandates for key survivor services,
but accounts for funding of these provisions, as well. I conclude that the ACA legislative does
have a positive impact on health care service accessibility for survivors. While the ACA
represents a monumental step forward for survivor health, it does so in a manner that excludes
explicit mentions of IPV, thereby straying from VAWA’s main goals to instead address
underserved health needs, more generally. Future legislation can further improve upon the
federal IPV response by incorporating VAWA’s exclusive targeting of IPV with ACA’s central
focus on health care and prevention.
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B. Limitations and Directions for Future Study
My findings and conclusions in this study are limited in the sense that I rely largely on
qualitative, secondary data. In using data collected by others, particularly by IPV advocacy
organizations and nonprofit groups like the Kaiser Family Foundation, my analysis is at greater
risk for the influence of normative bias. For example, while nonpartisan government officials
collect data sourced from the CRS and CBO, the data, analysis, and reports provided by nongovernmental sources may contain a partisan or ideology-based lens. My data and conclusions
are also limited in the fact that, as this study was the first attempt to comprehensively analyze the
ACA’s impact specifically on IPV survivors, there are very few quantitative studies detailing
service availability, funding, and utilization before and after ACA implementation. Plus, even
when studies of CHC service utilization are available, they do not report specifically on increases
in service utilization by IPV survivors, but by the entire population of people seeking care at
CHCs. As a result, it cannot be fully determined whether the ACA has causally increased use of
comprehensive services by survivors. Services offered via CHC sites, and overall CHC capacity,
vary greatly by state under the ACA, as state-level discretion in implementing the ACA’s
Medicaid expansion produces widespread disparities in the legislation’s funding levels. A more
detailed analysis of services for survivors in states that expanded Medicaid, as compared to states
that did not expand Medicaid, was not included in the scope of this paper. Finally, as explicated
in the Research Design section, my data is also limited in that, as the ACA only began full
implementation in 2014, its long-term impact on health outcomes cannot yet be determined.
In light of these limitations, a central question for future research will be the extent to
which IPV survivor positive health outcomes, including mental health and violence prevention,
are causally related to ACA provisions. While the ACA promotes prevention, primarily through
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preventive screenings, future studies must also examine the effectiveness of post-screening
interventions. For example, one possible future research question is: to what extent are
preventive screenings related to reduction in violence victimization, connection to the services
most necessary for survivors, and improvement in survivor health? Lastly, this study very
narrowly examined ACA provisions in comparison to VAWA, and through the lens of IPV
survivor health care. As the ACA produced such sweeping reforms to all sectors of the U.S.
health care systems and health insurance markets, future studies must go further in examining the
full scope of ACA provisions impacting survivors, beyond this study’s limited focus on CHCs.
C. Implications and Future Policy Recommendations
In examining the legislative histories, policy provisions, and implementation effects of
the ACA in comparison to VAWA legislation, it becomes clear that the ACA provides a more
comprehensive, proactive response to IPV than previous legislative efforts. While the ACA
implemented significant supports for survivors, several persistent challenges point to key areas
for reform and improvement. Overall, the ACA can be improved in terms of IPV survivor health
by adding provisions specifically focused on survivors as a vulnerable, high-risk health
population. As exhibited in this analysis, the ACA advanced several provisions that do aid IPV
survivor health, but only within a broad sense; the specific focus on domestic and sexual
violence promoted by VAWA’s framework therefore becomes overshadowed in this allencompassing health care reform bill. Beyond this, in January of 2013, the U.S. Preventative
Services Task Force found sufficient evidence to recommend domestic violence screening and
interventions in health settings for women of “childbearing age.” However, this emphasis on
women up to aged 46, coupled with a recent recognition of the prevalence of elder abuse, still
fail to address IPV negative health consequences for middle-aged women (Futures Without
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Violence 2015). As a result, this represents a missed opportunity under the ACA to intervene and
mitigate violence for the thousands of survivors facing repeated victimization within this undersupported age range. On a similar note, both the ACA and the VAWA legislation that came
before it continue to emphasize IPV as chiefly an issue of “violence against women.” While the
ACA no longer refers to IPV using the narrow language of “battered women,” and includes more
gender-inclusive terminology, the ACA still mandates preventive screening, and referrals to
counseling, through annual well-woman visits. Future policy has the potential to be even more
impactful than existing legislation by extending supports aimed at male survivors, and working
to reiterate that IPV is not just a “women’s issue.”
In surveying CHCs to gain a better understanding of health center challenges, it becomes
clear that high numbers of uninsured patients remain listed as the top challenge, particularly in
states that did not expand Medicaid under the ACA. In addition, CHCs face difficulties in
insufficient insurance reimbursement, and in workforce recruitment and retention (Paradise et al
2017). Several of these persistent impediments to comprehensive care stem from instability in
CHC funding. Despite the ACA’s provisions establishing funding mandates and grants for
CHCs, both the CRS and nonprofit reports emphasize the looming problem of “funding cliffs”
for CHCs. Even under the ACA, CHCs receive funding only in the short-term, typically through
two-year grant periods. Such funding lapses have a highly disruptive effect on essential health
center operations. More permanent, long-term funding of these health centers will be a crucial
step forward in ensuring stability and accessibility of services for IPV survivors, and in
preventing disruption in care. To promote long-term funding, the Kaiser Family Foundation
report “Community Health Centers: Growing Importance in a Changing Health Care System”
recommends expanding CHC grant funding periods to a 10-year funding approach, similar to
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federal funding for the Children’s Health Insurance Program (CHIP). This proposed policy could
stabilize the primary care system, therefore securing “a crucial dimension of access and quality”
(Kaiser Family Foundation 2018). A 10-year funding strategy could additionally enable CHCs to
make long-term operational decisions, including expansion of services vital to CHC survivors,
without concern over whether funding would be available from one year to the next to finance
such expansions. Longer-term funding therefore addresses the exact issues most detrimental to
IPV survivor healthcare, and facilitates delivery of the proximate services most crucial to
survivor health.
Initial reports of the first years of ACA implementation strongly support continued
investment in primary care, a prevention-focused health system, and CHCs in order to meet
health care needs of vulnerable patients in the U.S. (Adashi et al 649). As IPV survivors
exemplify some of the most at-risk patients, with extremely high likelihood of co-occurring
negative health outcomes, the ACA’s emphasis on both prevention and on CHC funding is a
highly effective tool towards promoting positive health for these survivors. However, both
VAWA and the ACA fail to implement, fund, or fully support the exhaustive list of
“comprehensive services” advocated by public health scholars, as was articulated in the
Literature Review and Research Design. Alarmingly, the 2016 Attorney General Report on
Effectiveness of Grant Programs under VAWA exposed numerous remaining areas of need to
make federal funding for IPV survivor health more impactful. For example, despite the
policymakers’ attempt to guarantee core services for survivors under the ACA, IPV advocates
identify that the ACA still falls short in sustaining these services, particularly in terms of
funding, and ensuring that services are offered at both rural and urban CHCs.
Finally, future policy can complement, and enhance, ACA provisions through measures
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to reduce delays in access to health care appointments, as well as through longer-term and betterdefined “counseling” for survivors. Waiting for health care is detrimental for all people, as
greater delays in addressing health issues may exacerbate both symptoms and long-term health
issues, however, delays in care are exceptionally dangerous for survivors who may face
continual abuse without intervention. Even once survivors have been removed from a situation of
continued violence, the ACA mandates remain vague in defining “counseling” services
available, and often only provide coverage for counseling for short periods of time. This is
insufficient in addressing the complex, and often slowly emerging, mental health consequences
of IPV. Thus, future policy efforts must work to both reduce health care delays under ACA
health plans, and extend counseling services.
The ACA can be improved to enhance organizational capacity, and to bolster guaranteed
support for treatment of co-occurring health needs. The ACA can also be amended to ensure that
education and prevention strategies are modernized, and remain relevant and effective. This
highlights the need for continued re-examination of existing federal health policy provisions, and
crafting of more expansive, consistently funded provisions directly targeting the areas of greatest
need for survivors.
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